Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	CDHR5 ADGRV1 FAT2 CDH20 CRNN PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 HMCN1 PCDHGA12 VCAN SLIT1 LRP2 NINL PCDHGA8 PCDH9 NIN	9.34e-08	749	196	25	GO:0005509
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-A HLA-B HLA-C HLA-H	1.09e-06	9	196	4	GO:0042610
GeneOntologyMolecularFunction	TAP complex binding	HLA-A HLA-B HLA-C HLA-H	1.09e-06	9	196	4	GO:0062061
GeneOntologyMolecularFunction	TAP1 binding	HLA-A HLA-B HLA-C HLA-H	1.81e-06	10	196	4	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-A HLA-B HLA-C HLA-H	1.81e-06	10	196	4	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-A HLA-B HLA-C HLA-H	1.81e-06	10	196	4	GO:0046977
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-A HLA-B HLA-C HLA-H	4.19e-06	12	196	4	GO:0030881
GeneOntologyMolecularFunction	protein-folding chaperone binding	HLA-A ERN1 HLA-B HLA-C HLA-H FNIP1 BAG2 TERT LRP2 RNF207	4.43e-06	161	196	10	GO:0051087
GeneOntologyMolecularFunction	MHC class I protein binding	HLA-A HLA-B HLA-C MFSD6 HLA-H	1.41e-05	32	196	5	GO:0042288
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	HLA-A HLA-B HLA-C HLA-H	1.94e-05	17	196	4	GO:0046703
GeneOntologyMolecularFunction	MHC protein binding	HLA-A HLA-B HLA-C MFSD6 HLA-H KIR3DL2	2.19e-05	58	196	6	GO:0042287
GeneOntologyMolecularFunction	T cell receptor binding	HLA-A HLA-B HLA-C HLA-H	3.86e-05	20	196	4	GO:0042608
GeneOntologyMolecularFunction	peptide antigen binding	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	1.16e-04	49	196	5	GO:0042605
GeneOntologyMolecularFunction	enzyme activator activity	ARHGAP32 GAPVD1 EREG TNFRSF10C CLPX FNIP1 RASA4B MLST8 FN1 APAF1 TOPBP1 ALS2 SIPA1 RGS20 RASA4 ARHGAP45 SOS1	2.68e-04	656	196	17	GO:0008047
GeneOntologyMolecularFunction	plus-end directed microfilament motor activity	MYO10 MYO3A	2.86e-04	3	196	2	GO:0060002
GeneOntologyMolecularFunction	protein kinase B binding	PDE3B SIRT1 APPL1	5.72e-04	17	196	3	GO:0043422
GeneOntologyMolecularFunction	14-3-3 protein binding	HLA-A HLA-B HLA-C HLA-H	7.53e-04	42	196	4	GO:0071889
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO10 MYO3A KIF14 KIF5A DNHD1 DYNC2H1	1.10e-03	118	196	6	GO:0003774
GeneOntologyMolecularFunction	heat shock protein binding	TPR ERN1 BAG2 APAF1 FAF1 RNF207 HTT	1.16e-03	163	196	7	GO:0031072
GeneOntologyMolecularFunction	keratin filament binding	VIM SIRT1	1.40e-03	6	196	2	GO:1990254
GeneOntologyMolecularFunction	GTPase activator activity	ARHGAP32 GAPVD1 RASA4B ALS2 SIPA1 RGS20 RASA4 ARHGAP45 SOS1	1.80e-03	279	196	9	GO:0005096
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CDHR5 PTK7 FAT2 CDH20 PKD1 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 HMCN1 PCDHGA12 PCDHGA8 PCDH9	1.09e-15	187	194	20	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	MCAM CDHR5 PTK7 FAT2 CDH20 PKD1 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 HMCN1 PCDHGA12 PCDHGA8 PCDH9	2.15e-12	313	194	21	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	HLA-A MYO10 HLA-DQA2 CD300A MCAM CDHR5 ADGRV1 BCL6 PTK7 EFR3A FAT2 CDH20 PKD1 CRNN PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 EPB41L5 PCDHAC2 PCDHA12 PCDHA5 CD200R1 CELSR3 HMCN1 PCDHGA12 SMARCE1 PCDHGA8 PCDH9	6.99e-09	1077	194	32	GO:0098609
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent	HLA-A HLA-B HLA-C HLA-H	5.16e-07	8	194	4	GO:0002485
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-C MFSD6 HLA-H	5.42e-07	18	194	5	GO:0042590
GeneOntologyBiologicalProcess	cell morphogenesis	TANC2 ASXL1 ARHGAP32 MYO10 BCL6 BRWD3 PTK7 MYO3A CDH20 PTPRQ KIF5A BRWD1 VIM FN1 FZD3 FAT3 CNMD EPB41L5 PCDHAC2 ALS2 SIPA1 TECTA PRPF40A CELSR3 TNN SLIT1 LRP2 SOS1 NIN	2.51e-06	1194	194	29	GO:0000902
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen	HLA-A HLA-B HLA-C HLA-DQA2 MFSD6 HLA-H	5.66e-06	48	194	6	GO:0002478
GeneOntologyBiologicalProcess	serotonergic neuron axon guidance	FZD3 PCDHAC2 CELSR3	8.08e-06	5	194	3	GO:0036515
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	HLA-A HLA-B HLA-C HLA-H	1.26e-05	16	194	4	GO:0002486
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	HLA-A HLA-B HLA-C HLA-H	1.64e-05	17	194	4	GO:0002484
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib	HLA-A HLA-B HLA-C HLA-H	1.64e-05	17	194	4	GO:0002476
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous antigen	HLA-A HLA-B HLA-C HLA-DQA2 MFSD6 HLA-H	1.73e-05	58	194	6	GO:0019884
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class Ib	HLA-A HLA-B HLA-C HLA-H	2.09e-05	18	194	4	GO:0002428
GeneOntologyBiologicalProcess	inner ear development	HLA-A HLA-B HLA-C HLA-H ADGRV1 PTK7 MYO3A PTPRQ FAT4 FZD3 TECTA	2.91e-05	253	194	11	GO:0048839
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class I	HLA-A HLA-B HLA-C MFSD6 HLA-H	3.98e-05	41	194	5	GO:0002474
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-C HLA-H	5.84e-05	23	194	4	GO:0019885
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	ARHGAP32 BCL6 KIF14 RASA4B EPS8L2 RASGRF1 ALS2 GRIN2A SIPA1 RASA4 ARHGAP45 SOS1	7.84e-05	333	194	12	GO:0051056
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen	HLA-A HLA-B HLA-C HLA-DQA2 MFSD6 HLA-H	8.11e-05	76	194	6	GO:0048002
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen	HLA-A HLA-B HLA-C HLA-H	8.22e-05	25	194	4	GO:0002483
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	HLA-A HLA-B HLA-C HLA-H	8.22e-05	25	194	4	GO:0002475
GeneOntologyBiologicalProcess	cell cycle process	TPR EREG RAD21L1 DAZL CNTLN ACVR1B BCL6 FANCA ANAPC1 RRS1 PKD1 MLH1 CRNN KIF14 TAF2 TOPBP1 C10orf90 TEX14 TERT PRPF40A SIRT1 EIF4G1 CIAO2B APPL1 SMARCE1 CCNB1IP1 PCM1 HTT NIN	8.36e-05	1441	194	29	GO:0022402
GeneOntologyBiologicalProcess	ear development	HLA-A HLA-B HLA-C HLA-H ADGRV1 PTK7 MYO3A PTPRQ FAT4 FZD3 TECTA	8.52e-05	285	194	11	GO:0043583
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	TANC2 ARHGAP32 PTK7 MYO3A PTPRQ KIF5A VIM FN1 FZD3 FAT3 PCDHAC2 ALS2 TECTA CELSR3 TNN SLIT1 LRP2 SOS1 NIN	8.65e-05	748	194	19	GO:0048667
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	TANC2 ARHGAP32 HLA-A HLA-B HLA-C MYO10 HLA-H CDHR5 PTK7 MYO3A VIM EPS8L2 FN1 FAT3 SIRT1 TNN SLIT1 MPHOSPH9 HTT NIN	1.48e-04	846	194	20	GO:0120035
GeneOntologyBiologicalProcess	microtubule anchoring at centrosome	NINL PCM1 NIN	1.69e-04	12	194	3	GO:0034454
GeneOntologyBiologicalProcess	neuron projection development	TANC2 ARHGAP32 HLA-A HLA-B HLA-C HLA-H ADGRV1 PTK7 MYO3A KIF5A VIM FAT4 FN1 RASGRF1 FZD3 FAT3 PCDHAC2 ALS2 TECTA SIRT1 CELSR3 TNN SLIT1 LRP2 SOS1 NIN	1.85e-04	1285	194	26	GO:0031175
GeneOntologyBiologicalProcess	regulation of cell projection organization	TANC2 ARHGAP32 HLA-A HLA-B HLA-C MYO10 HLA-H CDHR5 PTK7 MYO3A VIM EPS8L2 FN1 FAT3 SIRT1 TNN SLIT1 MPHOSPH9 HTT NIN	1.92e-04	863	194	20	GO:0031344
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous antigen	HLA-A HLA-B HLA-C HLA-H	2.22e-04	32	194	4	GO:0019883
GeneOntologyBiologicalProcess	chromosome localization	RAD21L1 RRS1 MLH1 KIF14 NUP98 TEX14 SIRT1	2.33e-04	130	194	7	GO:0050000
GeneOntologyBiologicalProcess	regulation of hydrolase activity	GAPVD1 CD300A TNFRSF10C BCL6 ANGPTL3 FNIP1 RASA4B MLST8 RASGRF1 APAF1 ALS2 RFFL GRIN2A NCSTN SIRT1 RASA4 VCAN SERPINA10 ARHGAP45 HTT	2.41e-04	878	194	20	GO:0051336
GeneOntologyBiologicalProcess	neuron development	TANC2 ARHGAP32 HLA-A HLA-B HLA-C HLA-H ADGRV1 PTK7 MYO3A PTPRQ KIF5A VIM FAT4 FN1 RASGRF1 FZD3 FAT3 PCDHAC2 ALS2 TECTA SIRT1 CELSR3 TNN SLIT1 LRP2 HTT SOS1 NIN	2.59e-04	1463	194	28	GO:0048666
GeneOntologyBiologicalProcess	midbrain morphogenesis	FZD3 SOS1	2.62e-04	3	194	2	GO:1904693
GeneOntologyBiologicalProcess	folate import across plasma membrane	SLC19A1 LRP2	2.62e-04	3	194	2	GO:1904447
GeneOntologyBiologicalProcess	microtubule anchoring at microtubule organizing center	NINL PCM1 NIN	2.76e-04	14	194	3	GO:0072393
GeneOntologyBiologicalProcess	telomere localization	RAD21L1 MLH1 NUP98	3.43e-04	15	194	3	GO:0034397
GeneOntologyBiologicalProcess	mRNA transport	TPR SMG1 NCBP1 MVP NUP98 IGF2BP2 HTT	4.52e-04	145	194	7	GO:0051028
GeneOntologyBiologicalProcess	regulation of mitotic cell cycle	TPR EREG BCL6 ANAPC1 PKD1 KIF14 FZD3 TOPBP1 C10orf90 TEX14 TERT SIRT1 EIF4G1 APPL1 SMARCE1	5.19e-04	594	194	15	GO:0007346
GeneOntologyBiologicalProcess	calcium-independent cell-matrix adhesion	PKD1 FN1	5.22e-04	4	194	2	GO:0007161
GeneOntologyCellularComponent	MHC class Ib protein complex	HLA-A HLA-B HLA-C HLA-H	2.57e-07	7	196	4	GO:0032398
GeneOntologyCellularComponent	MHC class I protein complex	HLA-A HLA-B HLA-C HLA-H	1.51e-06	10	196	4	GO:0042612
GeneOntologyCellularComponent	MHC protein complex	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	3.86e-06	26	196	5	GO:0042611
GeneOntologyCellularComponent	MHC class I peptide loading complex	HLA-A HLA-B HLA-C HLA-H	6.97e-06	14	196	4	GO:0042824
GeneOntologyCellularComponent	cis-Golgi network membrane	HLA-A HLA-B HLA-C HLA-H	1.62e-05	17	196	4	GO:0033106
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	1.78e-05	35	196	5	GO:0098553
GeneOntologyCellularComponent	Golgi medial cisterna	HLA-A HLA-B HLA-C HLA-H	5.77e-05	23	196	4	GO:0005797
GeneOntologyCellularComponent	lumenal side of membrane	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	8.50e-05	48	196	5	GO:0098576
GeneOntologyCellularComponent	pericentriolar material	BBS9 AKAP9 PCM1 NIN	1.29e-04	28	196	4	GO:0000242
GeneOntologyCellularComponent	centriole	CNTLN CROCC2 CEP162 C10orf90 MPHOSPH9 PCM1 HTT NIN	2.25e-04	172	196	8	GO:0005814
GeneOntologyCellularComponent	cell projection membrane	MYO10 CDHR5 ADGRV1 BBS9 PKD1 BRWD1 EPS8L2 EPB41L5 GRIN2A SLC9A3 SLC19A1 LRP2 ARHGAP45	2.26e-04	431	196	13	GO:0031253
GeneOntologyCellularComponent	ER to Golgi transport vesicle membrane	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	3.35e-04	64	196	5	GO:0012507
GeneOntologyCellularComponent	endoplasmic reticulum exit site	HLA-A HLA-B HLA-C HLA-H	6.35e-04	42	196	4	GO:0070971
GeneOntologyCellularComponent	early endosome	CLTCL1 HLA-A HLA-B HLA-C HLA-H SNX8 ANGPTL3 KIR3DL2 ALS2 NCSTN SLC9A3 APPL1 HTT	6.40e-04	481	196	13	GO:0005769
GeneOntologyCellularComponent	recycling endosome membrane	HLA-A HLA-B HLA-C HLA-H RFFL SLC9A3	6.61e-04	112	196	6	GO:0055038
GeneOntologyCellularComponent	filopodium tip	MYO10 MYO3A FZD3	8.23e-04	20	196	3	GO:0032433
GeneOntologyCellularComponent	early endosome membrane	HLA-A HLA-B HLA-C HLA-H SNX8 KIR3DL2 SLC9A3 APPL1	9.01e-04	212	196	8	GO:0031901
GeneOntologyCellularComponent	coated vesicle membrane	EREG CLTCL1 HLA-A HLA-B HLA-C HLA-DQA2 HLA-H LRP2	9.86e-04	215	196	8	GO:0030662
GeneOntologyCellularComponent	endocytic vesicle	GAPVD1 EREG CLTCL1 HLA-A HLA-B HLA-C HLA-DQA2 HLA-H VIM LRP2 APPL1	1.04e-03	384	196	11	GO:0030139
GeneOntologyCellularComponent	endoplasmic reticulum protein-containing complex	HLA-A ERN1 HLA-B HLA-C HLA-H FAF1	1.17e-03	125	196	6	GO:0140534
GeneOntologyCellularComponent	recycling endosome	CLTCL1 HLA-A HLA-B HLA-C HLA-H AMOTL2 RFFL SLC9A3	1.21e-03	222	196	8	GO:0055037
GeneOntologyCellularComponent	cis-Golgi network	HLA-A HLA-B HLA-C HLA-H AKAP9	1.23e-03	85	196	5	GO:0005801
GeneOntologyCellularComponent	cluster of actin-based cell projections	CDHR5 ADGRV1 MYO3A PTPRQ EPS8L2 SLC9A3 SLC19A1 LRP2	1.25e-03	223	196	8	GO:0098862
GeneOntologyCellularComponent	apical part of cell	CDHR5 C2CD2L PIP PTPRQ AMOTL2 FAT4 FN1 FZD3 DYNC2H1 SLC9A3 SLC19A1 LRP2 PCM1 NIN	1.44e-03	592	196	14	GO:0045177
GeneOntologyCellularComponent	condensed nuclear chromosome	RAD21L1 RRS1 MLH1 TOPBP1 CCNB1IP1	1.67e-03	91	196	5	GO:0000794
GeneOntologyCellularComponent	CD95 death-inducing signaling complex	TNFRSF10C FAF1	2.36e-03	8	196	2	GO:0031265
GeneOntologyCellularComponent	centrosome	CNTLN BBS9 CROCC2 ILRUN EPS8L2 CEP162 TOPBP1 ALS2 C10orf90 PPP4C AKAP9 KIAA1217 NINL MPHOSPH9 PCM1 NIN	2.52e-03	770	196	16	GO:0005813
GeneOntologyCellularComponent	condensed chromosome	TPR RAD21L1 RRS1 MLH1 NUP98 TOPBP1 TEX14 SMARCE1 CCNB1IP1	2.53e-03	307	196	9	GO:0000793
GeneOntologyCellularComponent	microtubule organizing center	CNTLN BBS9 CROCC2 ILRUN VIM EPS8L2 CEP162 TOPBP1 ALS2 C10orf90 PPP4C AKAP9 KIAA1217 NINL MPHOSPH9 PCM1 HTT NIN	2.61e-03	919	196	18	GO:0005815
MousePheno	spinal cord inflammation	HLA-A HLA-B HLA-C HLA-H	1.14e-06	8	161	4	MP:0030987
Domain	Cadherin_CS	CDHR5 FAT2 CDH20 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8 PCDH9	1.12e-15	109	192	17	IPR020894
Domain	CADHERIN_1	CDHR5 FAT2 CDH20 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8 PCDH9	2.09e-15	113	192	17	PS00232
Domain	CADHERIN_2	CDHR5 FAT2 CDH20 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8 PCDH9	2.43e-15	114	192	17	PS50268
Domain	-	CDHR5 FAT2 CDH20 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8 PCDH9	2.43e-15	114	192	17	2.60.40.60
Domain	CA	CDHR5 FAT2 CDH20 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8 PCDH9	2.83e-15	115	192	17	SM00112
Domain	Cadherin-like	CDHR5 FAT2 CDH20 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8 PCDH9	3.29e-15	116	192	17	IPR015919
Domain	Cadherin	CDHR5 FAT2 CDH20 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8 PCDH9	4.41e-15	118	192	17	IPR002126
Domain	Cadherin	FAT2 CDH20 PCDHB1 FAT4 PCDHGA9 PCDHGA5 FAT3 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8 PCDH9	3.84e-14	113	192	16	PF00028
Domain	Cadherin_2	PCDHB1 PCDHGA9 PCDHGA5 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8 PCDH9	5.61e-11	65	192	11	PF08266
Domain	Cadherin_N	PCDHB1 PCDHGA9 PCDHGA5 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8 PCDH9	5.61e-11	65	192	11	IPR013164
Domain	Cadherin_tail	PCDHGA9 PCDHGA5 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8	8.62e-08	37	192	7	PF15974
Domain	Cadherin_CBD	PCDHGA9 PCDHGA5 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8	8.62e-08	37	192	7	IPR031904
Domain	MHC_I_a_C	HLA-A HLA-B HLA-C HLA-H	1.60e-07	6	192	4	IPR010579
Domain	MHC_I_C	HLA-A HLA-B HLA-C HLA-H	1.60e-07	6	192	4	PF06623
Domain	Cadherin_C	PCDHB1 PCDHGA9 PCDHGA5 PCDHB10 PCDHAC2 PCDHGA12 PCDHGA8	2.16e-07	42	192	7	IPR032455
Domain	Cadherin_C_2	PCDHB1 PCDHGA9 PCDHGA5 PCDHB10 PCDHAC2 PCDHGA12 PCDHGA8	2.16e-07	42	192	7	PF16492
Domain	-	ADGRV1 FAT2 FAT4 COL16A1 FAT3 CELSR3 SLIT1 LRBA	6.10e-06	95	192	8	2.60.120.200
Domain	Laminin_G	FAT2 FAT4 COL16A1 FAT3 CELSR3 SLIT1	2.83e-05	58	192	6	IPR001791
Domain	EGF	EREG FAT2 FAT4 FAT3 TECTA CELSR3 HMCN1 TNN VCAN SLIT1 LRP2	3.29e-05	235	192	11	SM00181
Domain	EGF_CA	FAT2 FAT4 FAT3 CELSR3 HMCN1 VCAN SLIT1 LRP2	3.82e-05	122	192	8	SM00179
Domain	LAM_G_DOMAIN	FAT2 FAT4 FAT3 CELSR3 SLIT1	4.15e-05	38	192	5	PS50025
Domain	EGF-like_Ca-bd_dom	FAT2 FAT4 FAT3 CELSR3 HMCN1 VCAN SLIT1 LRP2	4.29e-05	124	192	8	IPR001881
Domain	EGF	EREG FAT2 TECTA CELSR3 HMCN1 VCAN SLIT1 LRP2	4.81e-05	126	192	8	PF00008
Domain	Laminin_G_2	FAT2 FAT4 FAT3 CELSR3 SLIT1	5.35e-05	40	192	5	PF02210
Domain	EGF-like_dom	EREG FAT2 FAT4 FAT3 TECTA CELSR3 HMCN1 TNN VCAN SLIT1 LRP2	5.57e-05	249	192	11	IPR000742
Domain	MHC_I	HLA-A HLA-B HLA-C HLA-H	5.65e-05	21	192	4	PF00129
Domain	MHC_I_a_a1/a2	HLA-A HLA-B HLA-C HLA-H	5.65e-05	21	192	4	IPR001039
Domain	EGF_1	EREG FAT2 FAT4 FN1 FAT3 CELSR3 HMCN1 TNN VCAN SLIT1 LRP2	6.90e-05	255	192	11	PS00022
Domain	EGF-like_CS	EREG FAT2 FAT4 FN1 FAT3 CELSR3 HMCN1 TNN VCAN SLIT1 LRP2	8.49e-05	261	192	11	IPR013032
Domain	LamG	FAT2 FAT4 FAT3 CELSR3 SLIT1	8.55e-05	44	192	5	SM00282
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT4 FAT3 CELSR3 HMCN1 VCAN SLIT1 LRP2	1.12e-04	106	192	7	IPR000152
Domain	EGF_3	EREG FAT2 FAT4 FAT3 CELSR3 HMCN1 TNN VCAN SLIT1 LRP2	1.65e-04	235	192	10	PS50026
Domain	C1-set	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	2.29e-04	54	192	5	PF07654
Domain	IGc1	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	2.72e-04	56	192	5	SM00407
Domain	-	RASA4B RASA4	3.13e-04	3	192	2	4.10.1130.10
Domain	Ig/MHC_CS	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	3.21e-04	58	192	5	IPR003006
Domain	Ig_C1-set	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	3.21e-04	58	192	5	IPR003597
Domain	IG_MHC	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	3.76e-04	60	192	5	PS00290
Domain	EGF_2	EREG FAT2 FAT4 FAT3 CELSR3 HMCN1 TNN VCAN SLIT1 LRP2	4.31e-04	265	192	10	PS01186
Domain	RasGAP	GAPVD1 RASA4B RASA4	4.44e-04	15	192	3	PF00616
Domain	RAS_GTPASE_ACTIV_1	GAPVD1 RASA4B RASA4	4.44e-04	15	192	3	PS00509
Domain	RAS_GTPASE_ACTIV_2	GAPVD1 RASA4B RASA4	4.44e-04	15	192	3	PS50018
Domain	ConA-like_dom	ADGRV1 FAT2 RANBP10 FAT4 COL16A1 FAT3 CELSR3 SLIT1 LRBA	4.51e-04	219	192	9	IPR013320
Domain	EGF_Ca-bd_CS	FAT4 FAT3 HMCN1 VCAN SLIT1 LRP2	4.97e-04	97	192	6	IPR018097
Domain	-	GAPVD1 RASA4B RASA4	5.43e-04	16	192	3	1.10.506.10
Domain	EGF_CA	FAT4 FAT3 HMCN1 VCAN SLIT1 LRP2	5.54e-04	99	192	6	PS01187
Domain	ASX_HYDROXYL	FAT4 FAT3 CELSR3 HMCN1 VCAN LRP2	5.84e-04	100	192	6	PS00010
Domain	MHC_I/II-like_Ag-recog	HLA-A HLA-B HLA-C HLA-DQA2	6.08e-04	38	192	4	IPR011162
Domain	RasGAP_dom	GAPVD1 RASA4B RASA4	7.79e-04	18	192	3	IPR001936
Domain	ARM-type_fold	SMG1 CLTCL1 NCBP1 EFR3A TAF2 TANGO6 ARMC6 EIF4G1 EFR3B LRBA HTT	7.93e-04	339	192	11	IPR016024
Domain	Protocadherin	PCDH11Y PCDH9	1.03e-03	5	192	2	PF08374
Domain	Protocadherin	PCDH11Y PCDH9	1.03e-03	5	192	2	IPR013585
Domain	IG_LIKE	HLA-A HLA-B HLA-C HLA-DQA2 CD300A HLA-H MCAM PTK7 KIR3DL2 CD200R1 HMCN1 VCAN GPA33	1.75e-03	491	192	13	PS50835
Domain	-	HLA-A HLA-B HLA-C	1.85e-03	24	192	3	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-A HLA-B HLA-C	1.85e-03	24	192	3	IPR011161
Domain	Rho_GTPase_activation_prot	ARHGAP32 GAPVD1 RASA4B RASA4 ARHGAP45	2.14e-03	88	192	5	IPR008936
Domain	Ig-like_dom	HLA-A HLA-B HLA-C HLA-DQA2 CD300A HLA-H MCAM PTK7 KIR3DL2 CD200R1 HMCN1 VCAN GPA33	2.16e-03	503	192	13	IPR007110
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-C HLA-H	8.92e-07	9	132	4	MM14527
Pathway	REACTOME_DAP12_INTERACTIONS	HLA-A HLA-B HLA-C HLA-H KIR3DL2 SOS1	1.07e-05	54	132	6	MM14871
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	1.57e-05	6	132	3	M47468
Pathway	REACTOME_ER_PHAGOSOME_PATHWAY	HLA-A HLA-B HLA-C HLA-H	2.03e-05	18	132	4	MM14525
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	2.73e-05	7	132	3	M47582
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	2.73e-05	7	132	3	M47530
Pathway	BIOCARTA_CTL_PATHWAY	HLA-A HLA-B HLA-C HLA-H	3.17e-05	20	132	4	MM1374
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	HLA-A HLA-B HLA-C HLA-DQA2 KIR3DL2	3.81e-05	41	132	5	M13519
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	HLA-A HLA-B HLA-C HLA-H	7.98e-05	25	132	4	MM15713
Pathway	BIOCARTA_NKCELLS_PATHWAY	HLA-A HLA-B HLA-C HLA-H	7.98e-05	25	132	4	MM1465
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-C	1.25e-04	11	132	3	M525
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	1.66e-04	12	132	3	M47529
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	HLA-A HLA-B HLA-C CD300A HLA-H KIR3DL2 CD200R1	2.76e-04	135	132	7	MM14781
Pathway	KEGG_ALLOGRAFT_REJECTION	HLA-A HLA-B HLA-C HLA-DQA2	3.82e-04	37	132	4	M18615
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	FAT2 PCDHB1 PCDHGA9 PCDHGA5 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8 PCDH9	1.14e-15	80	200	13	10716726
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	CDHR5 PCDHB1 PCDHGA9 PCDHGA5 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8 PCDH9	1.51e-14	74	200	12	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	FAT2 PCDHB1 PCDHGA9 PCDHGA5 PCDH11Y PCDHB10 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8 PCDH9	2.48e-14	77	200	12	10835267
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	FAT2 PCDHB1 PCDHGA9 PCDHGA5 PCDHB10 PCDHAC2 PCDHA12 PCDHA5 CELSR3 PCDHGA12 PCDHGA8	3.84e-13	72	200	11	10380929
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHB1 PCDHGA9 PCDHGA5 PCDHB10 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8	2.11e-10	68	200	9	11230163
Pubmed	Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.	HLA-A HLA-B HLA-C MFSD6 HLA-H	3.30e-10	8	200	5	17010536
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TANC2 TRPS1 CLPX BRWD3 C2CD2L ANAPC1 MLH1 CRNN TAF2 ARMC6 BRWD1 TUT4 FAT3 BAG2 SIPA1 PRPF40A SIRT1 TTC7A IGF2BP2 CIAO2B LRP2 SMARCE1 CRYBG3 SRRM2 PCM1 SOS1 NIN	3.38e-10	1116	200	27	31753913
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMG1 KDM3A GAPVD1 ADGRV1 KDM6B EFR3A MAST4 AMOTL2 CEP162 ZNF507 TOPBP1 FASTKD2 NCSTN MIER1 CELSR3 EFR3B NINL NIN	2.07e-09	529	200	18	14621295
Pubmed	Patterned variation in murine MHC promoters.	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	4.58e-09	12	200	5	12134058
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 ARHGAP32 GAPVD1 PDE3B FSIP2 MAST4 MAP3K9 KIF14 FNIP1 VIM KRT78 CEP162 EPB41L5 ALS2 AKAP9 AASS KIAA1217 EIF4G1 MPHOSPH9 CRYBG3 SRRM2 PCM1	6.25e-09	861	200	22	36931259
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM3A HLA-A HLA-B TRPS1 NCBP1 KDM6B BRWD3 PKD1 KIF5A AMOTL2 MLST8 MVP BRWD1 VIM FN1 FAF1 CELSR3 EIF4G1 CIAO2B LRP2 APPL1 SMARCE1 LRBA USPL1 PCM1 LRRFIP1 SOS1	6.90e-09	1285	200	27	35914814
Pubmed	Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain.	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	7.42e-09	13	200	5	9973410
Pubmed	Extensive polymorphism surrounding the murine Ia A beta chain gene.	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	7.42e-09	13	200	5	6311906
Pubmed	The I region of the C57BL/10 mouse: characterization and physical linkage to H-2K of an SB beta-like class II pseudogene, psi A beta 3.	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	1.15e-08	14	200	5	3860873
Pubmed	Further studies on polymorphic expression of GM1 and GD1a in mouse liver. The presence of a third allele on the Ggm-1 locus.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2808323
Pubmed	Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	12459592
Pubmed	A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	28234229
Pubmed	Induction of the H-2 D antigen during B cell activation.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2642506
Pubmed	A complex major histocompatibility complex D locus variant generated by an unusual recombination mechanism in mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	9037062
Pubmed	Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	20957233
Pubmed	Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	11580250
Pubmed	Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	20974936
Pubmed	The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	10704462
Pubmed	A novel H-2K splice form: predictions for other alternative H-2 splicing events.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2908875
Pubmed	Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	3458188
Pubmed	Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	19462379
Pubmed	Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6300887
Pubmed	H-2-linked regulation of xenotropic murine leukemia virus expression.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6300850
Pubmed	The assembly of H2-Kb class I molecules translated in vitro requires oxidized glutathione and peptide.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	8500526
Pubmed	cDNA clone coding for part of a mouse H-2d major histocompatibility antigen.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6265910
Pubmed	DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2906539
Pubmed	A single nucleotide difference at the 3' end of an intron causes differential splicing of two histocompatibility genes.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	3013627
Pubmed	Structure of a gene encoding a murine thymus leukemia antigen, and organization of Tla genes in the BALB/c mouse.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	3894562
Pubmed	Evolution of the mouse H-2K region: a hot spot of mutation associated with genes transcribed in embryos and/or germ cells.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	1348042
Pubmed	H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	19346486
Pubmed	Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	18383043
Pubmed	A physical map of the Q region of B1O.P.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	8833240
Pubmed	Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	21178009
Pubmed	Extensive deletions in the Q region of the mouse major histocompatibility complex.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	3025084
Pubmed	The class I major histocompatibility antigen gene activated in a line of SV40-transformed mouse cells is H-2Dd, not Qa/Tla.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2989712
Pubmed	Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	1280760
Pubmed	Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6786753
Pubmed	Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6583704
Pubmed	Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6571712
Pubmed	Probing for membrane domains in the endoplasmic reticulum: retention and degradation of unassembled MHC class I molecules.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	12006653
Pubmed	Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	7520098
Pubmed	Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	10452993
Pubmed	Adopting the rapamycin trapping assay to track the trafficking of murine MHC class I alleles, H-2K(b).	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	26714929
Pubmed	Clusters of genes encoding mouse transplantation antigens.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6280871
Pubmed	Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	10799615
Pubmed	Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	10993729
Pubmed	MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	19454713
Pubmed	Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	10229092
Pubmed	Molecular studies of murine mutant BALB/c-H-2dm2 define a deletion of several class I genes including the entire H-2Ld gene.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2879284
Pubmed	Amino acid sequence of the carboxyl-terminal hydrophilic region of the H-2Kb MHC alloantigen. Completion of the entire primary structure of the H-2Kb molecule.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	7306483
Pubmed	Molecular evidence that the H-2D and H-2L genes arose by duplication. Differences between the evolution of the class I genes in mice and humans.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2351932
Pubmed	Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	1731192
Pubmed	Detailed mapping of the Rfv-1 gene that influences spontaneous recovery from Friend retrovirus-induced leukaemia.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	1627536
Pubmed	The Impact of MHC Class I Dose on Development and Maintenance of the Polyclonal Naive CD8+ T Cell Repertoire.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	32341060
Pubmed	H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2422118
Pubmed	MHC class I H2-Kb negatively regulates neural progenitor cell proliferation by inhibiting FGFR signaling.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	34181639
Pubmed	Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	15809355
Pubmed	Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	3840195
Pubmed	Mouse histocompatibility genes: structure and organisation of a Kd gene.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	11894934
Pubmed	Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	19700752
Pubmed	The DNA sequence of the H-2kb gene: evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibilty antigens.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	11894963
Pubmed	Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	22287714
Pubmed	Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: a D/L hybrid gene.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2997361
Pubmed	Nucleotide sequences of three H-2K and three H-2D complementary DNA clones coding mouse class I MHC heavy chain proteins.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	9869916
Pubmed	Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	312902
Pubmed	The nucleotide sequence of the H-2K gene of C3Hf/HeN mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	3335396
Pubmed	Alternative RNA splicing in expression of the H-2K gene.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6689056
Pubmed	H2-M3-restricted CD8+ T cells are not required for MHC class Ib-restricted immunity against Listeria monocytogenes.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	16461341
Pubmed	A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6895187
Pubmed	Genetic control of corticosteroid side-chain isomerase activity in the mouse.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6822218
Pubmed	The structure of H-2K(b) and K(bm8) complexed to a herpes simplex virus determinant: evidence for a conformational switch that governs T cell repertoire selection and viral resistance.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	15210799
Pubmed	NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	19820922
Pubmed	Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	8181071
Pubmed	Generation of tissue-specific H-2Kd transgenic mice for the study of K(d)-restricted malaria epitope-specific CD8+ T-cell responses in vivo.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	23142461
Pubmed	Structure of C-terminal half of two H-2 antigens from cloned mRNA.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6895103
Pubmed	Nucleotide sequences of H2g7 K and D loci of nonobese diabetic mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	7759137
Pubmed	A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6799575
Pubmed	Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	6966299
Pubmed	Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	12140378
Pubmed	Structural analysis of TL genes of the mouse.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2410925
Pubmed	Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	12421934
Pubmed	Molecular cloning and sequencing of H-2Kk cDNA: comparison with other H-2 genes and evidence for alternative splicing.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	3840763
Pubmed	Competition between MHC class I alleles for cell surface expression alters CTL responses to influenza A virus.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	12421940
Pubmed	Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	9770513
Pubmed	Ethanol metabolism alters major histocompatibility complex class I-restricted antigen presentation in liver cells.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	19195028
Pubmed	Structural definition of the H-2Kd peptide-binding motif.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	16473882
Pubmed	HLA-G transgenic mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	10479061
Pubmed	Structural relationships among the H-2 D-regions of murine MHC haplotypes.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2909618
Pubmed	Structural analysis of H-2Kj and H-2Ku.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	8168857
Pubmed	BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	20534453
Pubmed	A single-chain H-2Db molecule presenting an influenza virus nucleoprotein epitope shows enhanced ability at stimulating CD8+ T cell responses in vivo.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	19342630
Pubmed	Inactivation of the H-2Klk gene could involve the substitutions of methylated CpGs.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	2212699
Pubmed	Class Ia MHC-deficient BALB/c mice generate CD8+ T cell-mediated protective immunity against Listeria monocytogenes infection.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	12817010
Pubmed	Transcription of HLA-G transgenes commences shortly after implantation during embryonic development in mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	7530689
Pubmed	MHC class I polymorphism in lupus-prone MRL/Mp mice.	HLA-A HLA-B HLA-C HLA-H	3.66e-08	7	200	4	8781130
Interaction	YWHAH interactions	TANC2 ARHGAP32 GAPVD1 PDE3B DHX38 MAST4 MAP3K9 KIF14 FNIP1 PPIL2 KIF5A AMOTL2 VIM KRT78 FN1 CEP162 EPB41L5 ALS2 SIPA1 FAF1 AKAP9 AASS KIAA1217 EIF4G1 NINL APPL1 MPHOSPH9 CRYBG3 LRBA SRRM2 PCM1 HTT NIN	9.61e-09	1102	198	33	int:YWHAH
Interaction	DNAJB6 interactions	CLTCL1 MYO10 PGM1 RRS1 MAP3K9 KIF14 NOL8 EPS8L2 BAG2 IDH2 TEX14 CIAO2B LRBA RBM34 HTT NIN	1.14e-06	379	198	16	int:DNAJB6
Interaction	XAGE1A interactions	ADGRV1 FAT4 FZD3 FAT3 CELSR3 SRRM2	2.82e-06	41	198	6	int:XAGE1A
Interaction	YWHAG interactions	TANC2 ARHGAP32 GAPVD1 PDE3B CNTLN C2CD2L MAST4 MAP3K9 KIF14 FNIP1 KIF5A AMOTL2 VIM FN1 CEP162 EPB41L5 ALS2 SIPA1 PRPF40A FAF1 AKAP9 AASS EIF4G1 NINL APPL1 MPHOSPH9 LRBA SRRM2 PCM1 HTT	4.93e-06	1248	198	30	int:YWHAG
Interaction	XCL1 interactions	ADGRV1 COL6A2 FAT4 FAT3 VCAN	7.12e-06	28	198	5	int:XCL1
Interaction	ITGB3 interactions	TPR MYO10 DHX38 MCAM ANGPTL3 VIM FN1 MTHFD1 SRRM2 HTT	7.26e-06	170	198	10	int:ITGB3
Interaction	YWHAB interactions	TANC2 ARHGAP32 GAPVD1 PDE3B CNTLN MAST4 MAP3K9 KIF14 KIF5A AMOTL2 VIM FN1 RASGRF1 CEP162 EPB41L5 ALS2 SIPA1 AKAP9 AASS EIF4G1 NINL APPL1 MPHOSPH9 SRRM2 PCM1 HTT	7.37e-06	1014	198	26	int:YWHAB
Interaction	PCDHGA8 interactions	PCDHGA9 PCDHGA5 PCDHGA8	9.21e-06	5	198	3	int:PCDHGA8
Interaction	YWHAE interactions	TANC2 ARHGAP32 GAPVD1 PDE3B NCBP1 CNTLN MAST4 MAP3K9 KIF14 KIF5A AMOTL2 VIM AIMP2 FN1 RASGRF1 ALS2 FASTKD2 ANKZF1 FAF1 AKAP9 AASS APPL1 MPHOSPH9 LRBA SRRM2 ARHGAP45 PCM1 HTT NIN	1.55e-05	1256	198	29	int:YWHAE
Interaction	SYT2 interactions	ERN1 RANBP10 WDR70 EPB41L5 MIER1 PRPF40A SIRT1 FUNDC2 HTT	1.79e-05	150	198	9	int:SYT2
Interaction	STIL interactions	ARHGAP32 KIF14 KRT78 BAG2 AKAP9 KIAA1217 NINL MPHOSPH9 PCM1 NIN	1.92e-05	190	198	10	int:STIL
Interaction	KRT19 interactions	ARHGAP32 AMOTL2 VIM KRT78 FN1 CEP162 AKAP9 NINL SMARCE1 MPHOSPH9 PCM1 NIN	2.39e-05	282	198	12	int:KRT19
Interaction	TNIK interactions	TANC2 TPR ARHGAP32 MCAM KIF5A MVP BAG2 GRIN2A AKAP9 KIAA1217 SMARCE1 PCM1 HTT SOS1	2.58e-05	381	198	14	int:TNIK
Interaction	PXN interactions	HLA-A HLA-C GART DAZL PKD1 KIF14 FN1 BAG2 AKAP9 KIAA1217 MPHOSPH9 CRYBG3 NIN	2.79e-05	334	198	13	int:PXN
Interaction	DCANP1 interactions	FAT4 FZD3 FAT3 CELSR3	3.12e-05	19	198	4	int:DCANP1
Interaction	SYNE3 interactions	TANC2 ARHGAP32 PDE3B HLA-C ANAPC1 TXNDC16 KIF14 NUP98 PROSER1 NCSTN PRPF40A KIAA1217 MPHOSPH9 CRYBG3 NIN	3.51e-05	444	198	15	int:SYNE3
Interaction	HAUS2 interactions	SMG1 FXYD6 CEP162 NINL SMARCE1 PCM1 HTT NIN	3.52e-05	126	198	8	int:HAUS2
Interaction	YWHAZ interactions	TANC2 ASXL1 ARHGAP32 GAPVD1 PDE3B FSIP2 MYO3A MAST4 MAP3K9 KIF14 KATNIP KIF5A VIM KRT78 AIMP2 FN1 RASGRF1 CEP162 ALS2 SIPA1 TERT FAF1 AKAP9 AASS APPL1 MPHOSPH9 PCM1 HTT NIN	3.80e-05	1319	198	29	int:YWHAZ
Interaction	RYK interactions	HLA-A PTK7 VIM FAT4 PCDHGA5 FAT3 CELSR3 PCDHGA12 SLC19A1 PCDH9	4.89e-05	212	198	10	int:RYK
Interaction	MAPRE1 interactions	TANC2 MYO10 MAST4 KIF14 VIM FN1 CEP162 BAG2 NUP98 AKAP9 KIAA1217 EIF4G1 SMARCE1 SRRM2 PCM1 NIN	5.12e-05	514	198	16	int:MAPRE1
Interaction	IFT74 interactions	UBXN10 VIM CEP162 NINL SMARCE1 PCM1 LRRFIP1 NIN	5.18e-05	133	198	8	int:IFT74
Interaction	SIRPA interactions	MCAM VIM COL6A2 KRT34 EIF4G1 HTT SOS1	5.88e-05	100	198	7	int:SIRPA
Interaction	HAUS5 interactions	KIF14 KRT78 CEP162 BAG2 NINL PCM1 HTT NIN	6.06e-05	136	198	8	int:HAUS5
Interaction	ENO1 interactions	ASXL1 CLTCL1 GART BCL6 PGM1 PRDM2 FANCA TXNDC16 KIF14 FAT4 AIMP2 FN1 BAG2 IDH2 TERT FAF1 EIF4G1 SMARCE1 HTT	6.56e-05	701	198	19	int:ENO1
Interaction	LILRB1 interactions	HLA-A HLA-B HLA-C	1.07e-04	10	198	3	int:LILRB1
Interaction	LILRB2 interactions	HLA-A HLA-B HLA-C	1.07e-04	10	198	3	int:LILRB2
Interaction	PCDHGB1 interactions	C2CD2L FAT4 PCDHGA9 CELSR3 PCDHGA12 PCDH9	1.11e-04	77	198	6	int:PCDHGB1
Interaction	NF2 interactions	TPR MCAM FANCA KIF14 AMOTL2 MVP NCSTN HELQ TERT CCNB1IP1 USPL1 SRRM2 SOS1	1.12e-04	383	198	13	int:NF2
Interaction	LGALS1 interactions	EREG MCAM CDHR5 TNFRSF10C PTK7 KIF14 FAT4 FN1 FAT3 VCAN LRP2 PCDH9	1.15e-04	332	198	12	int:LGALS1
Interaction	RAE1 interactions	TPR MYO10 KDM6B UBXN10 AIMP2 FN1 NUP98 FAF1 PCM1 HTT	1.19e-04	236	198	10	int:RAE1
Interaction	KRT8 interactions	SMG1 PKD1 KIF14 VIM FN1 KRT33A KRT34 CEP162 FAF1 AKAP9 NINL MPHOSPH9 CRYBG3 NIN	1.24e-04	441	198	14	int:KRT8
Interaction	CEP170P1 interactions	TRPS1 AIMP2 BAG2 AKAP9 SMARCE1 PCM1 NIN	1.27e-04	113	198	7	int:CEP170P1
Interaction	APEX1 interactions	GAPVD1 CLTCL1 TRPS1 BCL6 PRDM2 PKD1 MLH1 AMOTL2 MLST8 NOL8 BRWD1 EPS8L2 RBPMS TUT4 RADX CEP162 WDR70 APAF1 TOPBP1 EPB41L5 TERT SIRT1 AASS EIF4G1 MPHOSPH9 MUTYH PCM1	1.28e-04	1271	198	27	int:APEX1
Interaction	BAG2 interactions	ASXL1 GAPVD1 MYO10 C3orf38 BRWD3 PTK7 KIF14 TAF2 TANGO6 ILRUN TUT4 FN1 DDX60 BAG2 NINL SRRM2 HTT	1.46e-04	622	198	17	int:BAG2
Interaction	RAB35 interactions	ARHGAP32 GAPVD1 PDE3B HLA-A HLA-B MCAM DMXL1 C2CD2L EFR3A KIF14 FN1 EPB41L5 SLC19A1 EFR3B LRP2 HTT	1.80e-04	573	198	16	int:RAB35
Interaction	PTPN4 interactions	TPR KIF14 GRIN2A SIRT1 SRRM2	1.86e-04	54	198	5	int:PTPN4
Cytoband	5q31	PCDHB1 PCDHGA9 PCDHGA5 PCDHB10 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8	2.33e-09	115	201	9	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	FNIP1 PCDHB1 PCDHGA9 PCDHGA5 PCDHB10 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8	9.07e-07	298	201	10	chr5q31
GeneFamily	Clustered protocadherins	PCDHB1 PCDHGA9 PCDHGA5 PCDHB10 PCDHAC2 PCDHA12 PCDHA5 PCDHGA12 PCDHGA8	1.15e-09	64	136	9	20
GeneFamily	Cadherin related	CDHR5 FAT2 FAT4 FAT3	6.76e-06	17	136	4	24
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	1.92e-05	44	136	5	588
GeneFamily	C1-set domain containing	HLA-A HLA-B HLA-C HLA-DQA2	2.75e-04	42	136	4	591
GeneFamily	VPS9 domain containing	GAPVD1 ALS2	2.43e-03	10	136	2	928
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4B RASA4	2.43e-03	10	136	2	830
GeneFamily	Non-clustered protocadherins	PCDH11Y PCDH9	3.53e-03	12	136	2	21
GeneFamily	WD repeat domain containing	BRWD3 DMXL1 MLST8 BRWD1 WDR70 APAF1 LRBA	3.71e-03	262	136	7	362
GeneFamily	UBX domain containing	UBXN10 FAF1	4.15e-03	13	136	2	364
GeneFamily	CD molecules\|Gamma-glutamyltransferases	GGTLC3 GGTLC1	4.15e-03	13	136	2	564
Coexpression	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H JCHAIN	4.18e-09	19	197	6	MM797
Coexpression	TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	9.31e-08	16	197	5	MM3766
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	TANC2 MFSD6 PRND AMOTL2 MVP VIM FN1 FAT3 IGF2BP2 HMCN1 KIAA1217 CRYBG3 SRRM2 LRRFIP1	2.95e-07	337	197	14	M13206
Coexpression	TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING	TPR HLA-A HLA-B HLA-C HLA-DQA2 HLA-H VIM SRRM2	4.04e-07	90	197	8	MM3756
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H MCAM	4.43e-07	39	197	6	MM3725
Coexpression	YU_MYC_TARGETS_DN	HLA-B HLA-C HLA-DQA2 HLA-H TXNDC16 SIPA1 ARHGAP45	8.01e-07	68	197	7	MM632
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	HLA-A HLA-B HLA-C TRPS1 HLA-H KDM6B MAST4 PKD1 PPIL2 COL16A1 FN1 MIER1 TTC7A SLC19A1 HTT	3.00e-06	470	197	15	MM1053
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	3.30e-06	31	197	5	MM3729
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H SRRM2	5.40e-06	59	197	6	MM3688
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	TANC2 TRPS1 BCL6 MAST4 BRWD1 GPC6 LRBA PCDH9 LRRFIP1	5.65e-06	169	197	9	M39230
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	TPR EREG GART NCBP1 ANAPC1 KIF14 NOL8 BRWD1 FN1 DYNC2H1 TOPBP1 PRPF40A FAF1 IGF2BP2 CELSR3 VCAN EIF4G1 RBM34	9.39e-06	721	197	18	M10237
Coexpression	TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 DHX38 HLA-H KDM6B BBS9 PPIL2 VIM	9.50e-06	228	197	10	MM3676
Coexpression	TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING	HLA-A HLA-B HLA-C HLA-H VIM	1.07e-05	39	197	5	MM3758
Coexpression	MIKKELSEN_NPC_ICP_WITH_H3K27ME3	HLA-A HLA-B HLA-C HLA-H	1.10e-05	19	197	4	MM862
Coexpression	TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING	HLA-A HLA-B HLA-C HLA-H	1.36e-05	20	197	4	MM3682
Coexpression	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	EREG MYO10 NCBP1 MLST8 NOL8 TANGO6 ILRUN PROSER1 MTHFD1 SLC19A1 VCAN EIF4G1 CCNB1IP1	1.42e-05	408	197	13	M11891
Coexpression	RUAN_RESPONSE_TO_TNF_UP	HLA-A HLA-B HLA-C HLA-H	1.68e-05	21	197	4	MM651
Coexpression	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	EREG MYO10 NCBP1 MLST8 NOL8 TANGO6 ILRUN PROSER1 MTHFD1 SLC19A1 VCAN EIF4G1 CCNB1IP1	1.70e-05	415	197	13	MM1028
Coexpression	GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP	MYO3A FAT2 COL6A2 IGF2BP2 CELSR3 VCAN JCHAIN CCNB1IP1 MUTYH	2.10e-05	199	197	9	M6395
Coexpression	GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	KDM3A HLA-A CLPX PGM1 PRDM2 FNIP1 MIER1 FAF1 SMARCE1	2.18e-05	200	197	9	M6943
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	2.43e-05	46	197	5	MM3712
Coexpression	TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING	HLA-A HLA-B HLA-C HLA-H	2.92e-05	24	197	4	MM3773
Coexpression	BAUS_TFF2_TARGETS_UP	HLA-A HLA-B HLA-C HLA-H GGTLC1	3.32e-05	49	197	5	MM1287
Coexpression	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	HLA-A HLA-B HLA-C HLA-H	3.46e-05	25	197	4	MM672
Coexpression	TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING	HLA-A HLA-B HLA-C HLA-H JCHAIN	3.67e-05	50	197	5	MM3805
Coexpression	SENESE_HDAC1_TARGETS_DN	FXYD6 EPS8L2 RBPMS COL16A1 PCDHB10 EPB41L5 IDH2 RASA4 AASS LRRFIP1	3.69e-05	267	197	10	M6100
Coexpression	TABULA_MURIS_SENIS_AORTA_AORTIC_ENDOTHELIAL_CELL_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H TNFRSF10C KDM6B VIM IDH2 SLC19A1 TMEM26	4.25e-05	329	197	11	MM3671
Coexpression	TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING	HLA-A HLA-B HLA-C HLA-H JCHAIN	4.45e-05	52	197	5	MM3808
Coexpression	GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	SMG1 HLA-A HLA-B GART DDX60 IDH2 PRPF40A EIF4G1	4.58e-05	170	197	8	M5657
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TPR SMG1 GAPVD1 HLA-A HLA-B HLA-C TRPS1 HLA-H PRDM2 EFR3A BRWD1 VIM TUT4 NUP98 SIPA1 MIER1 PRPF40A AKAP9 JCHAIN SMARCE1 LRBA ARHGAP45 PCM1 LRRFIP1 SOS1 NIN	5.70e-05	1492	197	26	M40023
Coexpression	TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H VIM	6.55e-05	91	197	6	MM3720
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	SMG1 ASXL1 ERN1 MYO10 KIF14 TUT4 PCM1 SOS1	6.85e-05	180	197	8	M8239
Coexpression	JACKSON_DNMT1_TARGETS_UP	EREG HLA-A HLA-B HLA-C HLA-H DAZL	7.40e-05	93	197	6	MM1185
Coexpression	LIN_NPAS4_TARGETS_UP	HLA-A HLA-B HLA-C MFSD6 HLA-H FXYD6 XKR6 RBM34	7.69e-05	183	197	8	MM767
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	TANC2 MYO10 TRPS1 RBPMS EPB41L5 KIAA1217 MACROD2 PCDH9 LRRFIP1	8.97e-05	240	197	9	M39236
Coexpression	TABULA_MURIS_SENIS_HEART_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H KDM6B VIM	9.42e-05	140	197	7	MM3705
Coexpression	LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX	TANC2 MYO10 TRPS1 RBPMS FAF1 MACROD2 LRBA	9.85e-05	141	197	7	M39235
Coexpression	TABULA_MURIS_SENIS_LUNG_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING	HLA-A HLA-B HLA-C TRPS1 HLA-H VIM CIAO2B	1.03e-04	142	197	7	MM3757
Coexpression	DURAND_STROMA_NS_UP	PDE3B HLA-A HLA-B HLA-C HLA-H RBPMS KIAA1217 PCDH9	1.15e-04	194	197	8	MM962
Coexpression	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	HLA-A HLA-B HLA-C HLA-H CNMD TMEM26 RNF207	1.22e-04	146	197	7	MM856
Coexpression	TABULA_MURIS_SENIS_HEART_MONOCYTE_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H KDM6B VIM	1.28e-04	147	197	7	MM3707
Coexpression	GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP	BHLHE41 ASXL1 HLA-A HLA-B BBS9 MYO3A MAST4 MTHFD1	1.33e-04	198	197	8	M5573
Coexpression	PAL_PRMT5_TARGETS_DN	HLA-A HLA-B HLA-C HLA-H	1.35e-04	35	197	4	MM674
Coexpression	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN	TANC2 BCL6 RRS1 TXNDC16 MVP BAG2 APAF1 FASTKD2	1.38e-04	199	197	8	M9872
Coexpression	GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN	CYLC2 PDE3B FXYD6 BCL6 PTK7 NOVA1 BAG2 ALS2	1.38e-04	199	197	8	M2921
Coexpression	GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP	CDHR5 BCL6 RANBP10 ANKZF1 SRRM2 PCDH9 MUTYH HTT	1.38e-04	199	197	8	M3182
Coexpression	TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H JCHAIN	1.38e-04	104	197	6	MM3812
Coexpression	GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN	TANC2 HLA-C MYO10 KDM6B BRWD1 DYNC2H1 SLC9A3 VCAN	1.42e-04	200	197	8	M8076
Coexpression	GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	PDE3B ERN1 PTK7 MAP3K9 SLC19A1 VCAN GPA33 HTT	1.42e-04	200	197	8	M8383
Coexpression	GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN	ASXL1 SNX8 MLH1 TANGO6 BRWD1 CELSR3 USPL1 ARHGAP45	1.42e-04	200	197	8	M7801
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	TPR CLTCL1 BCL6 FANCA MLH1 NUP98 CCNB1IP1 MUTYH PCM1 NIN	1.78e-04	323	197	10	M9150
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	HLA-A TRPS1 KDM6B MAST4 PKD1 PPIL2 COL16A1 FN1 MIER1 TTC7A SLC19A1 HTT	1.90e-04	457	197	12	M1613
Coexpression	TABULA_MURIS_SENIS_SPLEEN_B_CELL_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H JCHAIN	1.97e-04	111	197	6	MM3831
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE	HLA-A HLA-B HLA-C HLA-H TNFRSF10C ARMC6 FN1 FASTKD2	2.05e-04	211	197	8	MM17081
Coexpression	MATZUK_SPERMATOCYTE	BCL6 FANCA MLH1 TEX14 TERT	2.12e-04	72	197	5	M1831
Coexpression	MATZUK_SPERMATOCYTE	BCL6 FANCA MLH1 TEX14 TERT	2.26e-04	73	197	5	MM1234
Coexpression	LINDVALL_IMMORTALIZED_BY_TERT_DN	PTK7 AIMP2 FN1 KRT34 VCAN	2.26e-04	73	197	5	M1561
Coexpression	TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING	HLA-A HLA-B HLA-C HLA-H JCHAIN	2.41e-04	74	197	5	MM3796
Coexpression	HOWLIN_CITED1_TARGETS_1_UP	HLA-A HLA-B HLA-C HLA-H	2.52e-04	41	197	4	MM710
Coexpression	TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	2.57e-04	75	197	5	MM3718
Coexpression	DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED	COL6A2 COL16A1 FN1	2.63e-04	17	197	3	M47995
Coexpression	HU_GENOTOXIC_DAMAGE_4HR	HLA-A HLA-B HLA-C HLA-H	3.04e-04	43	197	4	MM1204
Coexpression	FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	TANC2 EREG C3orf38 KATNIP PCDHGA5 PCDHB10 PCDHGA8	3.12e-04	170	197	7	M2168
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE	HLA-A HLA-B HLA-C HLA-DQA2 CD300A HLA-H TNFRSF10C ARHGAP45	3.17e-04	225	197	8	MM17079
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	TANC2 RBPMS DYNC2H1 FAF1 MACROD2 LRBA PCDH9	3.23e-04	171	197	7	M39234
Coexpression	TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING	HLA-A HLA-B HLA-C HLA-H	3.32e-04	44	197	4	MM3775
Coexpression	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	PCDHAC2 PCDHA12 PCDHA5 PCDHGA12	3.62e-04	45	197	4	M13714
Coexpression	TABULA_MURIS_SENIS_LIMB_MUSCLE_B_CELL_AGEING	HLA-A HLA-B HLA-C HLA-H KDM6B VIM JCHAIN SRRM2	3.77e-04	231	197	8	MM3741
Coexpression	TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING	HLA-A HLA-B HLA-C HLA-H KDM6B	3.89e-04	82	197	5	MM3777
Coexpression	TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING	HLA-A HLA-B HLA-C HLA-H KDM6B VIM	3.90e-04	126	197	6	MM3709
Coexpression	AIZARANI_LIVER_C33_STELLATE_CELLS_2	FXYD6 MCAM VIM COL6A2 RBPMS PCM1	3.90e-04	126	197	6	M39132
Coexpression	TABULA_MURIS_SENIS_TRACHEA_FIBROBLAST_AGEING	HLA-A HLA-B HLA-C HLA-H FXYD6 KDM6B	4.06e-04	127	197	6	MM3856
Coexpression	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H	4.35e-04	84	197	5	MM1049
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	KDM3A ADGRV1 KDM6B FAT4 FN1 DDX60 EPB41L5 ZNF277 AASS KIAA1217 EFR3B PCDH9	4.60e-04	504	197	12	M2157
Coexpression	WU_CELL_MIGRATION	VIM COL6A2 RBPMS FN1 IGF2BP2 RGS20 VCAN	4.86e-04	183	197	7	M2001
Coexpression	CRX_DN.V1_DN	HLA-A CDH20 COL16A1 CNMD TECTA CRYBG3	4.99e-04	132	197	6	M2792
Coexpression	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	HLA-A HLA-B HLA-C HLA-H CNMD TMEM26	4.99e-04	132	197	6	MM841
Coexpression	BENPORATH_NANOG_TARGETS	KDM3A ASXL1 DHX38 GART DMXL1 FANCA MYO3A RRS1 MLH1 ARMC6 VIM RANBP10 RBPMS CNMD GPC6 KIAA1217 VCAN LRP2	5.02e-04	988	197	18	M6616
Coexpression	SERVITJA_ISLET_HNF1A_TARGETS_UP	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H MCAM VIM	5.18e-04	185	197	7	MM1072
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000	TANC2 SMG1 PDE3B HLA-C DMXL1 ZNF483 FNIP1 MACROD2 LRBA CCNB1IP1 HTT	1.32e-06	187	195	11	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	TANC2 TPR SMG1 MYO10 TRPS1 KDM6B EFR3A ANAPC1 FAT3 APAF1 GPC6 AKAP9 VCAN EIF4G1	1.38e-05	385	195	14	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_100	DMXL1 MAST4 COL6A2 CNMD GPC6 EIF4G1 PCDH9	1.44e-05	86	195	7	gudmap_developingGonad_e16.5_epididymis_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	HLA-C MYO10 NOVA1 FZD3 DYNC2H1 FAT3 EPB41L5 AKAP9	4.42e-05	139	195	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	TANC2 SMG1 PDE3B HLA-C DAZL DMXL1 ZNF483 KIF14 FNIP1 NOVA1 NOL8 BRWD1 ALS2 TEX14 SIRT1 FAF1 MACROD2 LRBA CCNB1IP1 HTT	7.07e-05	820	195	20	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_1000	ARHGAP32 ANAPC1 TAF2 NOL8 FZD3 APAF1 EPB41L5 PRPF40A VCAN NINL NIN	8.85e-05	293	195	11	gudmap_developingKidney_e15.5_Podocyte cells_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	HLA-B HLA-C MYO10 MFSD6 PRND ADGRV1 FANCA CDH20 NOVA1 NOL8 COL6A2 RBPMS COL16A1 FZD3 EPB41L5 PPP4C RASA4 TNN LRP2 NINL TMEM26 PCDH9	9.64e-05	976	195	22	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	TRPS1 KDM6B DMXL1 MAST4 FNIP1 COL6A2 COL16A1 FAT3 CNMD GPC6 KIAA1217 EIF4G1 PCDH9	1.03e-04	406	195	13	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	PDE3B HLA-B MYO10 MFSD6 TRPS1 PRND ADGRV1 CNTLN FANCA KATNIP NOVA1 NOL8 VIM FZD3 FAT3 EPB41L5 PRPF40A AKAP9 LRP2 LRBA TMEM26 PCDH9	1.07e-04	983	195	22	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200	DMXL1 MAST4 COL6A2 FAT3 CNMD GPC6 EIF4G1 PCDH9	1.53e-04	166	195	8	gudmap_developingGonad_e16.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200	DMXL1 MAST4 COL6A2 FAT3 CNMD GPC6 EIF4G1 PCDH9	1.53e-04	166	195	8	gudmap_developingGonad_e18.5_epididymis_200
CoexpressionAtlas	DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#2_top-relative-expression-ranked_500	TRPS1 TUT4 EPB41L5 GPC6 AKAP9	1.62e-04	56	195	5	gudmap_developingKidney_e15.5_Proximal Tubules_500_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	HLA-C MYO10 NCBP1 ADGRV1 NOVA1 NOL8 FZD3 DYNC2H1 FAT3 EPB41L5 AKAP9 LRP2 MPHOSPH9 PCM1	2.17e-04	498	195	14	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500	TRPS1 BRWD3 BRWD1 FAT4 PRPF40A APPL1 TMEM26	2.22e-04	132	195	7	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	BHLHE41 KDM3A EREG TRPS1 CNTLN BRWD3 ZNF483 KIF14 NOVA1 FAT4 TUT4 FAT3 GPC6 IGF2BP2 HMCN1 ZNF277 KIAA1217 VCAN SMARCE1	2.46e-04	831	195	19	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	RASA4B COL6A2 FN1 PCDHB10 CROCCP2 PCDHA12 PCDHA5 SLC9A3 RASA4 SLC19A1	2.84e-04	281	195	10	PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05	RASA4B COL6A2 FN1 PCDHB10 CROCCP2 PCDHA12 PCDHA5 SLC9A3 RASA4 SLC19A1	2.84e-04	281	195	10	PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	HLA-C MYO10 NCBP1 ADGRV1 NOVA1 NOL8 BRWD1 ILRUN TUT4 FZD3 DYNC2H1 CEP162 FAT3 EPB41L5 RFFL AKAP9 LRP2 NINL MPHOSPH9 LRBA PCM1	3.14e-04	989	195	21	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	TANC2 SMG1 MYO10 TRPS1 KDM6B EFR3A ANAPC1 TAF2 APAF1 GPC6 VCAN EIF4G1	3.21e-04	397	195	12	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	SMG1 HLA-A HLA-B HLA-C HLA-DQA2 CDH20 TXNDC16 DDX60 NUP98 PCM1 HTT	4.90e-10	176	200	11	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ASXL1 TUT4 WDR70 IGF2BP2 AKAP9 VCAN MACROD2 LRBA SRRM2 PCM1 SOS1	1.30e-09	193	200	11	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ASXL1 TUT4 WDR70 IGF2BP2 AKAP9 VCAN MACROD2 SRRM2 PCM1 SOS1	1.76e-08	192	200	10	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NOVA1 COL6A2 FAT4 RBPMS FN1 DYNC2H1 GPC6 VCAN CRYBG3	7.65e-08	169	200	9	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	SMG1 HLA-A HLA-B HLA-C CDH20 TXNDC16 NUP98 PCM1 HTT	1.14e-07	177	200	9	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 MAST4 RBPMS EPB41L5 XKR6 KIAA1217 MACROD2 LRBA PCDH9	1.73e-07	186	200	9	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTK7 VIM COL6A2 FAT4 COL16A1 FN1 GPC6 VCAN TMEM26	2.27e-07	192	200	9	f053b89bfd6048c227667ff01c38df7c51d8a496
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TANC2 PDE3B TRPS1 PTK7 FAT4 COL16A1 FN1 HMCN1 VCAN	2.82e-07	197	200	9	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BHLHE41 PGM1 PTK7 COL16A1 FN1 HMCN1 KIAA1217 TNN VCAN	2.94e-07	198	200	9	c55608633f66e3d434c5d81324efb07c5120d2c2
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BHLHE41 PGM1 PTK7 COL16A1 FN1 HMCN1 KIAA1217 TNN VCAN	2.94e-07	198	200	9	3e5459038fc6ed95f529eb4d1dc5113e16c19012
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VIM COL6A2 FAT4 COL16A1 FN1 PCDH11Y GPC6 VCAN PCDH9	3.20e-07	200	200	9	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NOVA1 VIM COL6A2 FAT4 COL16A1 FN1 GPC6 VCAN PCDH9	3.20e-07	200	200	9	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	TANC2 ADGRV1 MAST4 RBPMS RASGRF1 MACROD2 LRP2 PCDH9	1.61e-06	180	200	8	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR SMG1 TRPS1 TUT4 FN1 MIER1 PCM1 NIN	1.75e-06	182	200	8	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	ADGRV1 MAST4 RBPMS EPB41L5 AASS KIAA1217 MACROD2 PCDH9	1.98e-06	185	200	8	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR SMG1 TRPS1 TUT4 FN1 MIER1 PCM1 NIN	1.98e-06	185	200	8	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	ADGRV1 MAST4 RBPMS EPB41L5 KIAA1217 MACROD2 LRBA PCDH9	2.14e-06	187	200	8	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	SMG1 HLA-C HLA-DQA2 NCBP1 RASA4B VIM SRRM2 ARHGAP45	2.32e-06	189	200	8	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	TRPS1 NOVA1 VIM COL6A2 FN1 DYNC2H1 GPC6 VCAN	2.60e-06	192	200	8	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TANC2 ADGRV1 MAST4 RBPMS RASGRF1 MACROD2 LRP2 PCDH9	2.71e-06	193	200	8	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TANC2 ADGRV1 MAST4 RBPMS RASGRF1 MACROD2 LRP2 PCDH9	2.71e-06	193	200	8	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	TANC2 ADGRV1 MAST4 RBPMS RASGRF1 MACROD2 LRP2 PCDH9	2.71e-06	193	200	8	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE3B MYO10 FAT4 FN1 FAT3 GPC6 HMCN1 VCAN	2.81e-06	194	200	8	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EREG PKD1 VIM COL6A2 COL16A1 FN1 GPC6 VCAN	2.81e-06	194	200	8	ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TRPS1 VIM COL6A2 FN1 GPC6 VCAN RNF207 PCDH9	2.81e-06	194	200	8	85e00861c5068a27d0cf0ae677f420c8245baa9a
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ARHGAP32 PDE3B TRPS1 BCL6 NOVA1 COL6A2 DYNC2H1 VCAN	2.92e-06	195	200	8	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PTK7 MAST4 COL6A2 FAT4 FN1 FAT3 GPC6 VCAN	2.92e-06	195	200	8	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRV1 MAST4 EPS8L2 RBPMS EPB41L5 KIAA1217 MACROD2 RNF207	2.92e-06	195	200	8	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	PCW_05-06-Mesenchymal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TRPS1 CNTLN VIM COL6A2 FAT4 FN1 GPC6 VCAN	3.03e-06	196	200	8	dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 ADGRV1 WDR70 XKR6 FAF1 MACROD2 LRBA SOS1	3.03e-06	196	200	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTK7 VIM COL6A2 FAT4 COL16A1 FN1 GPC6 VCAN	3.03e-06	196	200	8	cbfe01ba8071864e19b37028236ae35789f630fe
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	MYO10 MCAM ADGRV1 MAST4 AMOTL2 VIM CNMD GRIN2A	3.15e-06	197	200	8	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	MYO10 MCAM ADGRV1 MAST4 AMOTL2 VIM CNMD GRIN2A	3.15e-06	197	200	8	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NOVA1 VIM COL6A2 FAT4 RBPMS FN1 GPC6 VCAN	3.27e-06	198	200	8	75d104eead681f6bf47c4dd24913cc768c9a1717
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A2 FAT4 COL16A1 FN1 FAT3 GPC6 HMCN1 VCAN	3.27e-06	198	200	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 ARHGAP32 ADGRV1 EPB41L5 XKR6 FAF1 MACROD2 LRBA	3.27e-06	198	200	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	TANC2 CEP162 PRPF40A AKAP9 APPL1 SMARCE1 LRRFIP1 SOS1	3.27e-06	198	200	8	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 TRPS1 WDR70 XKR6 FAF1 MACROD2 LRBA SOS1	3.40e-06	199	200	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NOVA1 FAT4 COL16A1 FN1 DYNC2H1 GPC6 RGS20 VCAN	3.40e-06	199	200	8	abd6117f8a3d7e798d8471c16d97b34aaf50fc9c
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRPS1 FXYD6 COL16A1 FN1 CNMD GPC6 TNN PCDH9	3.52e-06	200	200	8	be527df943a8cedc6452ecef3cafc282db34ceb8
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAST4 BRWD1 FAT4 TUT4 IGF2BP2 HMCN1 KIAA1217 NIN	3.52e-06	200	200	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRPS1 FXYD6 COL16A1 FN1 CNMD GPC6 TNN PCDH9	3.52e-06	200	200	8	8e41a484038216f0c2ad258fd46c0e702a4bb8bf
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NOVA1 COL6A2 FAT4 FN1 FAT3 GPC6 HMCN1 VCAN	3.52e-06	200	200	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPS1 FXYD6 COL16A1 FN1 CNMD GPC6 TNN PCDH9	3.52e-06	200	200	8	c935caef2988f165e96d8f1ef99ae8963ab9377f
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	MYO10 TRPS1 PGM1 CDH20 NOVA1 VIM RADX RGS20	3.52e-06	200	200	8	70c2e577efb6b6fe8f9d970d7ecc470788efb85b
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTK7 VIM COL6A2 COL16A1 FN1 GPC6 VCAN PCDH9	3.52e-06	200	200	8	ac8a5d71acd4d401995babd233f0d3738e8ad2a5
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MFSD6 TRPS1 FN1 DYNC2H1 VCAN LRP2 TMEM26	6.05e-06	153	200	7	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRV1 MAST4 EPS8L2 RBPMS EPB41L5 SLC19A1 MACROD2	7.78e-06	159	200	7	8680b054622f573a82b1625fb93c2d5db81d1034
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 PTPRQ FAT3 TECTA HMCN1 AASS LRP2	8.11e-06	160	200	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 PTPRQ FAT3 TECTA HMCN1 AASS LRP2	8.11e-06	160	200	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	ADGRV1 MAST4 RBPMS EPB41L5 KIAA1217 MACROD2 PCDH9	9.15e-06	163	200	7	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRV1 MAST4 EPS8L2 RBPMS EPB41L5 KIAA1217 MACROD2	1.20e-05	170	200	7	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	HLA-DQA2 DYNC2H1 NUP98 XKR6 CD200R1 RASA4 SOS1	1.35e-05	173	200	7	b9dee61973559e8c2fef3f2dafd43475b386befb
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EREG CD300A TXNDC16 SIRT1 VCAN CCNB1IP1 ARHGAP45	1.40e-05	174	200	7	b6e3fa995def40a8fbdfc249fe108c303931a171
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FXYD6 PTK7 COL16A1 GPC6 ANKZF1 TNN NINL	1.45e-05	175	200	7	aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DHX38 BCL6 MAP3K9 RBPMS DDX60 TMEM26 NIN	1.45e-05	175	200	7	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	KATNIP DYNC2H1 NUP98 XKR6 CD200R1 RASA4 SOS1	1.51e-05	176	200	7	437cfc5e06416bb0fc76d1f9dc106f74e279e880
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122\|Adult / Lineage, Cell type, age group and donor	ADGRV1 RBPMS EPB41L5 AASS KIAA1217 MACROD2 PCDH9	1.51e-05	176	200	7	3fee8a367bb9755aca1b7fcc968b08e51b6e9436
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ASXL1 AMOTL2 FN1 PROSER1 HMCN1 VCAN USPL1	1.62e-05	178	200	7	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRV1 MAST4 EPS8L2 RBPMS EPB41L5 SLC19A1 KIAA1217	1.68e-05	179	200	7	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 MAST4 RBPMS KIAA1217 MACROD2 LRBA PCDH9	1.68e-05	179	200	7	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-gdT\|Multiple_Sclerosis / Disease, Lineage and Cell Type	HLA-A ERN1 HLA-B HLA-C CD300A KIR3DL2 COL6A2	1.68e-05	179	200	7	ab8d8104b38603ec7fbc5b35d7149e71ad57c43a
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTK7 COL6A2 COL16A1 FN1 GRIN2A HMCN1 TNN	1.74e-05	180	200	7	935c091bbcd6d10b81dc4731779e5bd98205c99f
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A2 FAT4 RBPMS FN1 GPC6 TNN VCAN	1.74e-05	180	200	7	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	5'-Airway_Nasal-Mesenchymal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTK7 COL6A2 COL16A1 FN1 GRIN2A HMCN1 TNN	1.74e-05	180	200	7	3dd384b7f3d9582b8fec9fe05100e466e6218b76
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NOVA1 COL6A2 RBPMS FN1 GPC6 HMCN1 VCAN	1.87e-05	182	200	7	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTK7 COL6A2 COL16A1 FN1 GRIN2A HMCN1 TNN	1.94e-05	183	200	7	803376f5260de83c48d4f7301278d078a32b3e6e
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTK7 COL6A2 COL16A1 FN1 GRIN2A HMCN1 TNN	1.94e-05	183	200	7	6d98973098c6d20c5305bce6a83a549a7d8dbfba
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTK7 COL6A2 COL16A1 FN1 GRIN2A HMCN1 TNN	1.94e-05	183	200	7	cc7f5a17b40e8d901885174922e5fa8877643071
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRV1 MAST4 IDH2 SLC9A3 NINL LRBA PCDH9	1.94e-05	183	200	7	31ab55d5f3639f5964541d5eae23044dbda3356e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 PTPRQ KIF5A FAT4 FAT3 HMCN1 LRP2	2.01e-05	184	200	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 PTPRQ KIF5A FAT4 FAT3 HMCN1 LRP2	2.01e-05	184	200	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ADGRV1 MAST4 RBPMS RASGRF1 MACROD2 LRP2 PCDH9	2.01e-05	184	200	7	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 PTPRQ KIF5A FAT4 FAT3 HMCN1 LRP2	2.01e-05	184	200	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRV1 MAST4 IDH2 SLC9A3 NINL LRBA PCDH9	2.08e-05	185	200	7	898a093757f86be3e18d2ef1f16a71f50ef81dc3
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR KDM6B PRPF40A AKAP9 SRRM2 PCM1 LRRFIP1	2.23e-05	187	200	7	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	TANC2 GART MAST4 RBPMS RASGRF1 AASS MACROD2	2.30e-05	188	200	7	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR TRPS1 KDM6B PRPF40A AKAP9 SRRM2 LRRFIP1	2.30e-05	188	200	7	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ADGRV1 MAST4 EPS8L2 RBPMS EPB41L5 KIAA1217 MACROD2	2.30e-05	188	200	7	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 ADGRV1 BCL6 NOVA1 RBPMS GPC6 IGF2BP2	2.30e-05	188	200	7	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	droplet-Liver-nan-3m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAF2 DDX60 ANKZF1 IGF2BP2 SLIT1 TMEM26	2.37e-05	127	200	6	39fa20a55de3af1a62ab5dfa4877879db3935ac2
ToppCell	droplet-Marrow-BM-1m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GART PTK7 RRS1 IDH2 MTHFD1 RASA4 SLC19A1	2.38e-05	189	200	7	b81540e097e95158851e07bfd78640ed6e64c2cf
ToppCell	droplet-Marrow-BM-1m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GART PTK7 RRS1 IDH2 MTHFD1 RASA4 SLC19A1	2.38e-05	189	200	7	0fda1a3f1e87fadf5309c8267beaa4501983b1dd
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 FN1 DYNC2H1 FAT3 GPC6 HMCN1 SLIT1	2.38e-05	189	200	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 RBPMS SLC9A3 KIAA1217 MACROD2 LRBA PCDH9	2.38e-05	189	200	7	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 ADGRV1 PTK7 ZNF483 XKR6 MACROD2 PCDH9	2.38e-05	189	200	7	e059be2965cca70ff5576df055d0af1775b76e00
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 MAST4 PTPRQ EPB41L5 KIAA1217 MACROD2 LRBA	2.47e-05	190	200	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL6A2 COL16A1 FN1 FAT3 GPC6 HMCN1 VCAN	2.47e-05	190	200	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	BLOOD--(1)_gd_T_cells\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-A HLA-B HLA-C CD300A KIR3DL2 COL6A2 SIPA1	2.55e-05	191	200	7	47ced00ed6fb47ddc6e9baa76186ea974720defd
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	TANC2 ADGRV1 MAST4 RBPMS RASGRF1 MACROD2 LRP2	2.55e-05	191	200	7	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 MAST4 PTPRQ RBPMS EPB41L5 KIAA1217 MACROD2	2.55e-05	191	200	7	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ADGRV1 MAST4 EPS8L2 RBPMS EPB41L5 KIAA1217 MACROD2	2.64e-05	192	200	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	11.5-Distal\|11.5 / Age, Tissue, Lineage and Cell class	MYO10 PTK7 VIM COL6A2 FN1 FAT3 VCAN	2.64e-05	192	200	7	169b9ee2377beb9e4ad35bc82bb7a3dafe8f05b6
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	ADGRV1 MAST4 RBPMS RASGRF1 MACROD2 LRP2 PCDH9	2.64e-05	192	200	7	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 MAST4 RBPMS RASGRF1 C10orf90 KIAA1217 MACROD2	2.64e-05	192	200	7	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial-RG\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	BHLHE41 KDM3A HLA-B HLA-C MYO10 GART VIM	2.64e-05	192	200	7	ee822325bb32ac7ad1eeccc23d966367e90a9edd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRV1 MAST4 EPS8L2 IDH2 SLC9A3 AKAP9 PCDH9	2.64e-05	192	200	7	ee27d27e3d269764dbe8711d0b37ff9331a298a9
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	PDE3B MYO10 PTK7 FN1 FAT3 HMCN1 MACROD2	2.64e-05	192	200	7	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO10 COL6A2 FN1 FAT3 GPC6 HMCN1 AASS	2.73e-05	193	200	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAST4 EPB41L5 IGF2BP2 MACROD2 LRP2 NINL LRBA	2.73e-05	193	200	7	3866667dd221612589ae50f5c52f73a183a49ce6
Drug	Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A	MYO10 CLPX NOL8 BRWD1 WDR70 BAG2 NUP98 FASTKD2 APPL1 MPHOSPH9	4.87e-06	185	196	10	7209_DN
Drug	brinzolamide	HLA-A HLA-B ARHGAP45	6.20e-06	5	196	3	ctd:C111827
Drug	Pimozide [2062-78-4]; Down 200; 8.6uM; HL60; HG-U133A	KDM3A CLTCL1 CD300A BCL6 KDM6B PRDM2 MLST8 FN1 NUP98 ANKZF1	6.46e-06	191	196	10	1562_DN
Drug	AC1L1FCN	HLA-A HLA-B HLA-C KIR3DL2	6.75e-06	15	196	4	CID000003178
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	TPR MYO10 NCBP1 ACVR1B PRDM2 ILRUN VIM EIF4G1 LRP2 PCM1	6.77e-06	192	196	10	4104_DN
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	TANC2 FANCA KIF14 PPIL2 BRWD1 NUP98 EPB41L5 AKAP9 MPHOSPH9 PCDH9	6.77e-06	192	196	10	2865_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	CLTCL1 GART TRPS1 KDM6B PRDM2 MLST8 ARMC6 SLC19A1 VCAN MPHOSPH9	7.09e-06	193	196	10	2949_DN
Drug	Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; HL60; HT_HG-U133A	DHX38 TRPS1 ACVR1B PRDM2 FANCA BRWD1 RANBP10 TUT4 IDH2 SIPA1	7.76e-06	195	196	10	1267_DN
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A	GART PRDM2 PPIL2 CEP162 DDX60 SIRT1 AKAP9 ZNF277 MPHOSPH9 SRRM2	8.12e-06	196	196	10	2382_DN
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	ACVR1B KDM6B PRDM2 MAST4 PPIL2 SLC9A3 VCAN SRRM2 PCDH9 PCM1	8.49e-06	197	196	10	6605_UP
Drug	Isocarboxazid [59-63-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A	ERN1 TNFRSF10C ACVR1B MAP3K9 PPIL2 FN1 RASGRF1 SIPA1 LRP2 PCM1	8.87e-06	198	196	10	4706_UP
Drug	Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; PC3; HT_HG-U133A	PDE3B KDM6B C2CD2L PPIL2 APAF1 EPB41L5 PCDHA5 CELSR3 LRP2 RBM34	9.27e-06	199	196	10	4494_UP
Drug	AC1L1FHZ	TPR PRND RRS1 VIM AIMP2 APAF1 GRIN2A PRPF40A SIRT1 HTT	1.82e-05	215	196	10	CID000003244
Drug	CID9959010	HLA-B PRND PCDHGA12 TNN PCDHGA8	2.04e-05	39	196	5	CID009959010
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	TANC2 MYO10 TRPS1 MAST4 KIF14 RBPMS WDR70 NUP98 ZNF277	2.08e-05	174	196	9	7530_DN
Drug	CTK8G2960	TPR PRND RRS1 BAG2 APAF1 GRIN2A TERT PRPF40A HTT	3.52e-05	186	196	9	CID005361912
Drug	Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A	CLTCL1 MAST4 TUT4 FN1 DDX60 CNMD APAF1 TEX14 AKAP9	4.69e-05	193	196	9	4503_UP
Drug	Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	TANC2 TPR MYO10 PRDM2 PPIL2 BRWD1 ILRUN RBPMS PCM1	4.69e-05	193	196	9	4321_DN
Drug	Ethylnitrosourea	ADGRV1 PKD1 MLH1 BRWD1 RASGRF1 DYNC2H1 EPB41L5 NSUN7 SIRT1 JCHAIN HTT	4.70e-05	291	196	11	ctd:D005038
Drug	Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; HL60; HT_HG-U133A	PDE3B NCBP1 KDM6B BBS9 PPIL2 RBPMS ZNF277 LRP2 PCM1	4.88e-05	194	196	9	1267_UP
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	MAST4 MAP3K9 PPIL2 MVP VIM CEP162 LRP2 PCM1 SOS1	5.08e-05	195	196	9	2241_DN
Drug	Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A	ASXL1 GART MCAM MAST4 MLST8 ARMC6 ILRUN RBPMS NUP98	5.08e-05	195	196	9	1886_DN
Drug	Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A	TPR ACVR1B PPIL2 BRWD1 CEP162 IDH2 CELSR3 AASS SRRM2	5.50e-05	197	196	9	7311_UP
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PDE3B MYO10 GART KDM6B BBS9 PPIL2 FN1 WDR70 ARHGAP45	5.50e-05	197	196	9	7230_DN
Drug	Gabapentin [60142-96-3]; Up 200; 23.4uM; PC3; HT_HG-U133A	TPR TNFRSF10C PPIL2 BRWD1 CNMD APAF1 AASS LRP2 NINL	5.72e-05	198	196	9	5875_UP
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	PDE3B GART ACVR1B C2CD2L MAST4 MVP RBPMS ANKZF1 PCM1	5.72e-05	198	196	9	6838_DN
Drug	Chrysamine-G	PRND RRS1 APAF1 GRIN2A NCSTN PRPF40A	5.79e-05	78	196	6	CID005488970
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	TPR PRDM2 PPIL2 BRWD1 RBPMS DYNC2H1 CEP162 VCAN PCM1	5.95e-05	199	196	9	4316_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	C2CD2L FANCA MAST4 FN1 ANKZF1 SLC19A1 SRRM2 ARHGAP45 PCM1	5.95e-05	199	196	9	7439_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	MCAM TNFRSF10C ACVR1B KDM6B BBS9 AMOTL2 TUT4 DYNC2H1 SRRM2	5.95e-05	199	196	9	5219_UP
Drug	Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A	FANCA PPIL2 ARMC6 TUT4 FN1 NUP98 FAF1 HTT SOS1	5.95e-05	199	196	9	2045_DN
Drug	I-As	TPR PRND RRS1 COL6A2 APAF1 GRIN2A PRPF40A HTT	6.99e-05	158	196	8	CID000078017
Drug	AC1L2RDN	HLA-A IDH2	7.37e-05	2	196	2	CID000101705
Drug	tips--a	TERT PPP4C	7.37e-05	2	196	2	CID000167468
Drug	2,4,4'-trichlorobiphenyl	RAD21L1 CNTLN KDM6B BRWD3 FANCA FAT2 ANGPTL3 KIF5A NOVA1 ILRUN EPS8L2 KRT78 FN1 FAT3 TOPBP1 EPB41L5 ALS2 RFFL FASTKD2 GRIN2A TERT AKAP9 CELSR3 MACROD2 CRYBG3 LRBA PCDH9	8.14e-05	1411	196	27	ctd:C081766
Drug	benzoquinone	TPR PRND RRS1 BAG2 APAF1 GRIN2A TERT PRPF40A HTT	8.67e-05	209	196	9	CID000004650
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-A HLA-B HLA-C	9.02e-06	7	190	3	DOID:0081267 (implicated_via_orthology)
Disease	neutrophil count, basophil count	HLA-A HLA-C TNFRSF10C ACVR1B RBPMS PCDHA12 PCDHA5 XKR6 TERT	1.60e-05	224	190	9	EFO_0004833, EFO_0005090
Disease	mental development measurement	EFR3A PCDHGA9 PCDHGA5 PCDHGA8	1.90e-05	25	190	4	EFO_0008230
Disease	age at menarche	CYLC2 HLA-A MYO10 C3orf38 PRDM2 PTK7 ZNF483 BRWD1 HELQ PRPF40A IGF2BP2 SLIT1 EIF4G1 MACROD2	3.38e-05	594	190	14	EFO_0004703
Disease	–	HLA-A HLA-B	4.12e-05	2	190	2	608579
Disease	Susceptibility to severe cutaneous adverse reaction	HLA-A HLA-B	4.12e-05	2	190	2	cv:C1840548
Disease	Carbamazepine response	HLA-A HLA-B	4.12e-05	2	190	2	cv:CN077964
Disease	beta-2 microglobulin measurement	HLA-A HLA-B HLA-C	4.17e-05	11	190	3	EFO_0005197
Disease	joint hypermobility measurement	CROCC2 TUT4 XKR6 VCAN	5.89e-05	33	190	4	EFO_0007905
Disease	body weight	CYLC2 GAPVD1 HLA-B C3orf38 TRPS1 ADGRV1 BCL6 EFR3A MAST4 PKD1 FNIP1 ILRUN COL16A1 RASGRF1 WDR70 GPC6 IGF2BP2 KIAA1217 SLIT1 MACROD2 PCM1	6.86e-05	1261	190	21	EFO_0004338
Disease	Malignant Glioma	HLA-A HLA-B HLA-C DMXL1 TERT	9.05e-05	70	190	5	C0555198
Disease	mixed gliomas	HLA-A HLA-B HLA-C DMXL1 TERT	9.05e-05	70	190	5	C0259783
Disease	childhood trauma measurement, alcohol consumption measurement	TANC2 PCDHGA9 PCDHGA5 PCDHGA12 PCDHGA8	9.69e-05	71	190	5	EFO_0007878, EFO_0007979
Disease	R-6-hydroxywarfarin measurement	CYLC2 TRPS1 TNFRSF10C DDX60 LRBA PCDH9	9.87e-05	114	190	6	EFO_0803327
Disease	basophil count, eosinophil count	HLA-B TNFRSF10C KDM6B ANAPC1 FNIP1 CD200R1 SMARCE1 ARHGAP45	1.79e-04	241	190	8	EFO_0004842, EFO_0005090
Disease	Gastric Adenocarcinoma	ERN1 MLH1 MAP3K9 TEX14	2.02e-04	45	190	4	C0278701
Disease	esophagus squamous cell carcinoma (is_implicated_in)	FANCA MLH1 IDH2 TERT	2.02e-04	45	190	4	DOID:3748 (is_implicated_in)
Disease	Stevens-Johnson syndrome (is_implicated_in)	HLA-A HLA-B	2.45e-04	4	190	2	DOID:0050426 (is_implicated_in)
Disease	Glioma	HLA-A HLA-B HLA-C DMXL1 TERT	2.53e-04	87	190	5	C0017638
Disease	mean platelet volume	ARHGAP32 HLA-B HLA-C FANCA MAST4 SNX8 MVP PCDHGA9 PCDHGA5 TERT PCDHGA12 MACROD2 ARHGAP45 PCDHGA8 LRRFIP1 HTT NIN	3.43e-04	1020	190	17	EFO_0004584
Disease	clostridium difficile infection	EREG TRPS1 EFR3A GRIN2A LRBA PCDH9	3.52e-04	144	190	6	EFO_0009130
Disease	allergic asthma (is_implicated_in)	HLA-B HLA-C	4.07e-04	5	190	2	DOID:9415 (is_implicated_in)
Disease	chronic myeloid leukemia (implicated_via_orthology)	NCSTN SIPA1	4.07e-04	5	190	2	DOID:8552 (implicated_via_orthology)
Disease	Huntington's disease (is_implicated_in)	GRIN2A SIRT1 HTT	4.23e-04	23	190	3	DOID:12858 (is_implicated_in)
Disease	cortical surface area measurement	TANC2 HLA-B ADGRV1 CNTLN BBS9 PGM1 MAST4 PKD1 MLH1 NOVA1 TANGO6 FZD3 CEP162 FAT3 XKR6 FAF1 VCAN MACROD2 MPHOSPH9 SOS1	4.51e-04	1345	190	20	EFO_0010736
Disease	neutrophil count, eosinophil count	HLA-A HLA-C TNFRSF10C ACVR1B RBPMS XKR6 TERT	4.82e-04	213	190	7	EFO_0004833, EFO_0004842
Disease	neuroimaging measurement, brain volume measurement	TRPS1 MAST4 ILRUN FAT3 XKR6 FAF1 VCAN MACROD2	5.61e-04	286	190	8	EFO_0004346, EFO_0006930
Disease	childhood onset asthma, age at onset, environmental tobacco smoke exposure measurement	MACROD2 NIN	6.08e-04	6	190	2	EFO_0004847, EFO_0008361, MONDO_0005405
Disease	Adult only	MLH1 MUTYH	6.08e-04	6	190	2	C3842001
Disease	neutrophil count	HLA-A HLA-B HLA-C HLA-DQA2 TNFRSF10C ACVR1B KDM6B FANCA PKD1 RBPMS DYNC2H1 PCDHA12 PCDHA5 XKR6 TEX14 TERT SIRT1 LRBA ARHGAP45 HTT	6.33e-04	1382	190	20	EFO_0004833
Disease	blood urea nitrogen measurement	ADGRV1 FANCA CDH20 RBPMS MIER1 SIRT1 FAF1 CD200R1 LRP2 LRBA	7.41e-04	452	190	10	EFO_0004741
Disease	tuberculosis (is_implicated_in)	EREG HLA-A HLA-B	7.65e-04	28	190	3	DOID:399 (is_implicated_in)
Disease	aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)	GGTLC3 GGTLC1	8.48e-04	7	190	2	DOID:5022 (biomarker_via_orthology)
Disease	Drug-Induced Stevens Johnson Syndrome	HLA-A HLA-B HLA-C	8.49e-04	29	190	3	C1274933
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	HLA-A HLA-B HLA-C	8.49e-04	29	190	3	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	HLA-A HLA-B HLA-C	8.49e-04	29	190	3	C3658302
Disease	Toxic Epidermal Necrolysis	HLA-A HLA-B HLA-C	8.49e-04	29	190	3	C0014518
Disease	cervical cancer (is_implicated_in)	KDM3A HLA-B FANCA	9.39e-04	30	190	3	DOID:4362 (is_implicated_in)
Disease	Stevens-Johnson Syndrome	HLA-A HLA-B HLA-C	9.39e-04	30	190	3	C0038325
Disease	lymphocyte measurement	HLA-A ERN1 HLA-B HLA-C ANAPC1	9.83e-04	117	190	5	EFO_0803546
Disease	glycoprotein measurement	HLA-A HLA-B TRPS1 ADGRV1 XKR6	1.06e-03	119	190	5	EFO_0004555
Disease	alcohol dependence (biomarker_via_orthology)	GGTLC3 GGTLC1	1.13e-03	8	190	2	DOID:0050741 (biomarker_via_orthology)
Disease	memory impairment	FAT4 PRPF40A	1.13e-03	8	190	2	EFO_0001072
Disease	primary ovarian insufficiency (is_implicated_in)	BBS9 FANCA	1.13e-03	8	190	2	DOID:5426 (is_implicated_in)
Disease	Diabetes Mellitus	FN1 SIRT1 APPL1	1.14e-03	32	190	3	C0011849
Disease	cystatin C measurement	ADGRV1 FANCA FNIP1 EPB41L5 KIAA1217 GGTLC1 LRP2 NINL SOS1	1.25e-03	402	190	9	EFO_0004617
Disease	granulocyte count	HLA-A HLA-C TNFRSF10C ACVR1B RBPMS XKR6 TERT	1.35e-03	254	190	7	EFO_0007987
Disease	uveal melanoma (is_marker_for)	HLA-B MCAM	1.44e-03	9	190	2	DOID:6039 (is_marker_for)
Disease	Thyroid Gland Follicular Adenoma	TPR PRDM2 TERT	1.48e-03	35	190	3	C0151468
Disease	mosquito bite reaction itch intensity measurement	HLA-B HLA-DQA2 FNIP1 PCDH9 NIN	1.52e-03	129	190	5	EFO_0008377
Disease	amino acid measurement	TANC2 CLTCL1 TXNDC16 FAT4 FASTKD2 VCAN SLIT1 MACROD2 LRP2 APPL1 LRBA HTT	1.56e-03	678	190	12	EFO_0005134
Disease	Malignant neoplasm of breast	KDM3A EREG CDH20 VIM FN1 DYNC2H1 NUP98 TECTA HELQ TERT SIRT1 AKAP9 ZNF277 APPL1 LRBA LRRFIP1	1.66e-03	1074	190	16	C0006142
Disease	peripheral arterial disease, traffic air pollution measurement	TANC2 TRPS1 TXNDC16 MACROD2 LRBA MUTYH	1.66e-03	194	190	6	EFO_0004265, EFO_0007908
Disease	serum albumin measurement	HLA-B TRPS1 ADGRV1 SNX8 RBPMS EPB41L5 TERT NSUN7 IGF2BP2 SERPINA10 SOS1	1.67e-03	592	190	11	EFO_0004535
Disease	alcohol use disorder (implicated_via_orthology)	KDM3A KDM6B ANGPTL3 EPS8L2 SIRT1 SRRM2	1.70e-03	195	190	6	DOID:1574 (implicated_via_orthology)
Disease	Thyroid Neoplasm	TPR PRDM2 TERT	1.74e-03	37	190	3	C0040136
Disease	myelodysplastic syndrome	HLA-B TAF2	1.79e-03	10	190	2	EFO_0000198
Disease	Peritoneal Neoplasms	MCAM VIM	1.79e-03	10	190	2	C0031149
Disease	Carcinomatosis of peritoneal cavity	MCAM VIM	1.79e-03	10	190	2	C0346990
Disease	Nonsyndromic Deafness	ADGRV1 MYO3A EPS8L2 TECTA	1.88e-03	81	190	4	C3711374
Disease	acute myeloid leukemia (is_implicated_in)	ASXL1 FANCA IDH2 TERT	2.15e-03	84	190	4	DOID:9119 (is_implicated_in)
Disease	complement C1q tumor necrosis factor-related protein 5 measurement	HLA-B APAF1	2.18e-03	11	190	2	EFO_0801494
Disease	Adenocarcinoma of lung (disorder)	ERN1 GART RRS1 MLH1 SLC19A1 SOS1	2.24e-03	206	190	6	C0152013
Disease	susceptibility to Mycobacterium tuberculosis infection measurement	PDE3B HLA-A HLA-B HLA-C	2.34e-03	86	190	4	EFO_0008407
Disease	dermatomyositis	HLA-B PIP	2.61e-03	12	190	2	EFO_0000398
Disease	intracranial aneurysm (is_implicated_in)	PKD1 VCAN	2.61e-03	12	190	2	DOID:10941 (is_implicated_in)
Disease	total blood protein measurement	DHX38 PKD1 SNX8 KIR3DL2 RBPMS TERT NSUN7 ARHGAP45 SOS1	2.64e-03	449	190	9	EFO_0004536
Disease	nasopharynx carcinoma (is_marker_for)	KDM3A GRIN2A TERT	2.68e-03	43	190	3	DOID:9261 (is_marker_for)
Disease	immunoglobulin isotype switching measurement	HLA-B ARHGAP45 MUTYH	2.87e-03	44	190	3	EFO_0010128
Disease	hepatocyte growth factor measurement	BRWD1 HTT SOS1	2.87e-03	44	190	3	EFO_0006903
Disease	Thyroid carcinoma	TPR PRDM2 TERT	2.87e-03	44	190	3	C0549473
Disease	lymphocyte count	HLA-A HLA-B HLA-C ANAPC1 ILRUN RANBP10 RBPMS FN1 PCDHGA9 PCDHGA5 FAF1 IGF2BP2 PCDHGA12 MTHFD1 FUNDC2 SMARCE1 ARHGAP45 PCDHGA8 HTT	2.98e-03	1464	190	19	EFO_0004587
Disease	Degenerative polyarthritis	MVP VIM COL6A2 IDH2	3.11e-03	93	190	4	C0029408
Disease	Osteoarthrosis Deformans	MVP VIM COL6A2 IDH2	3.11e-03	93	190	4	C0086743
Disease	Craniofacial Abnormalities	TRPS1 APAF1 IDH2 GPC6 LRP2	3.46e-03	156	190	5	C0376634
Disease	frontal fibrosing alopecia	HLA-B MYO10 KIAA1217	3.67e-03	48	190	3	EFO_0009855
Disease	hearing impairment	ADGRV1 FANCA MYO3A TECTA	3.76e-03	98	190	4	C1384666
Disease	neuroticism measurement, cognitive function measurement	ASXL1 TRPS1 ZNF507 PCDHA12 PCDHA5 GRIN2A XKR6 KIAA1217 MPHOSPH9 PCDH9	3.84e-03	566	190	10	EFO_0007660, EFO_0008354
Disease	apolipoprotein B measurement	PDE3B HLA-B DHX38 TRPS1 SNX8 ARMC6 BRWD1 ILRUN FN1 SERPINA10 HTT	3.96e-03	663	190	11	EFO_0004615
Disease	Adenoid Cystic Carcinoma	KDM6B FANCA VCAN SMARCE1	4.04e-03	100	190	4	C0010606
Disease	severe aplastic anemia	HLA-B HLA-DQA2	4.10e-03	15	190	2	EFO_0006927
Disease	cleft lip (is_implicated_in)	MTHFD1 SLC19A1	4.10e-03	15	190	2	DOID:9296 (is_implicated_in)
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	HLA-B HLA-C	4.10e-03	15	190	2	EFO_0801746
Disease	gastroesophageal reflux disease	HLA-B ILRUN VCAN PCDH9	4.18e-03	101	190	4	EFO_0003948
Disease	diastolic blood pressure, systolic blood pressure	GAPVD1 TRPS1 BCL6 PTK7 TAF2 TANGO6 RANBP10 DYNC2H1 GPC6 PCM1 LRRFIP1	4.28e-03	670	190	11	EFO_0006335, EFO_0006336
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO3A PTPRQ TECTA	4.36e-03	51	190	3	cv:CN043650
Disease	brain connectivity measurement	ADGRV1 FANCA TANGO6 FAT3 FAF1 VCAN MACROD2 SOS1	4.56e-03	400	190	8	EFO_0005210
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	HLA-B DYNC2H1 TERT	4.61e-03	52	190	3	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	body mass index, type 2 diabetes mellitus	FAF1 IGF2BP2	4.66e-03	16	190	2	EFO_0004340, MONDO_0005148
Disease	obesity	CEP162 NUP98 KIAA1217 MACROD2 PCDH9 LRRFIP1	4.84e-03	241	190	6	EFO_0001073
Disease	Leukemia, Myelocytic, Acute	FXYD6 FANCA NUP98 IDH2 TERT	5.36e-03	173	190	5	C0023467
Disease	autism spectrum disorder, schizophrenia	HLA-A HLA-B HLA-C HLA-DQA2 HLA-H GRIN2A MPHOSPH9	5.45e-03	327	190	7	EFO_0003756, MONDO_0005090
Disease	sexual dimorphism measurement	GAPVD1 TRPS1 BCL6 PKD1 FNIP1 ILRUN RANBP10 RASGRF1 WDR70 GRIN2A SIPA1 FAF1 IGF2BP2 SLIT1 EFR3B	5.48e-03	1106	190	15	EFO_0021796
Disease	cortical thickness	HLA-B TRPS1 ADGRV1 BBS9 PGM1 CDH20 MAST4 PKD1 FZD3 FAT3 XKR6 FAF1 SLC19A1 VCAN MACROD2	5.80e-03	1113	190	15	EFO_0004840
Disease	mean reticulocyte volume	HLA-A HLA-B RBPMS PCDHGA5 ZNF510 TERT FAF1 TTC7A IGF2BP2 SLC19A1 KIAA1217 PCM1	5.83e-03	799	190	12	EFO_0010701
Disease	Glioblastoma Multiforme	ERN1 FN1 IDH2 TERT	5.84e-03	111	190	4	C1621958
Disease	interleukin-6 measurement	MYO3A ANAPC1 XKR6 GPC6	6.03e-03	112	190	4	EFO_0004810
Disease	uric acid measurement	ADGRV1 FANCA FAT4 DYNC2H1 FAT3 FAF1 CD200R1 IGF2BP2 RGS20 LRP2	6.41e-03	610	190	10	EFO_0004761

Protein segments in the cluster

Peptide	Gene	Start	Entry
VRFSNLSPESQQQDV	C2orf16	46	Q68DN1
PLDQVTESARTQLQV	C2orf16	481	Q68DN1
EILAPEDSQVLQQAT	AMOTL2	56	Q9Y2J4
TISEEEKVRNEPTQQ	APAF1	36	O14727
QTTPRTAQQNAERTE	FAM246C	196	P0DSO1
TISSEPERTNIQNLN	AKAP9	2576	Q99996
QEVNPVRQEIESETT	VCAN	2101	P13611
AEEIQTSRPQTITEQ	VCAN	2366	P13611
RILDSNDQATVNPVE	VCAN	3036	P13611
QQAEVEKQTSLTPRE	CLPX	211	O76031
SLAEENSQVTFPRIQ	CNTLN	1066	Q9NXG0
LSQDPNRVELVSSNT	CRYBG3	776	Q68DQ2
REFLVSEQPVNQSTQ	CRYBG3	1356	Q68DQ2
RSQTQTLESLEFIPQ	ALS2	1341	Q96Q42
IQRTQPSAELAAEND	BHLHE41	221	Q9C0J9
RDTQSNELIEINPQS	COL16A1	256	Q07092
DAVTDTIDIAPNQRV	ACVR1B	361	P36896
SDLQESVASSRPQEV	ARMC6	96	Q6NXE6
DQNDNPSQSRTVEIF	FAT4	3606	Q6V0I7
ESQNFSPVVRDAVIT	AASS	436	Q9UDR5
PSSDTVRVNILANDN	ADGRV1	2686	Q8WXG9
QANPSVLERDVDTQE	C1orf131	151	Q8NDD1
ESVVPERQQDSSLSE	BRWD3	1346	Q6RI45
PSQIRDNTVSIIDEE	CYLC2	51	Q14093
NQLRRTSIQEPTEIS	ANGPTL3	201	Q9Y5C1
SEQLLDQPESRNVST	DNHD1	4186	Q96M86
STVIPETQLQAEDRD	CDHR5	141	Q9HBB8
EAQVENLITANATEP	FXYD6	76	Q9H0Q3
RENDDQVLSASNPTV	DMXL1	1796	Q9Y485
QVDILSNNVPSDDVV	EFR3A	706	Q14156
SSQTSVAERLVEQPQ	ASXL1	766	Q8IXJ9
QSIISTVEPAQRQEA	PGM1	41	P36871
RPQTEAEVLEQSAQT	RASA4	401	O43374
FTQNQSRPEEITLRE	RAD21L1	131	Q9H4I0
TETPIQEEQASIKNR	RANBP10	281	Q6VN20
NTPSEANLQEEEVRT	RBPMS	11	Q93062
EEEESTSQIERPLSQ	RBM34	86	P42696
SRQDIITLQDPTNLD	PPIL2	151	Q13356
RPQTEAEVLEQSAQT	RASA4B	401	C9J798
TVQDVNDNAPEVILT	PCDHGA5	336	Q9Y5G8
SVEDVNDNRPEVIIT	PCDHGA8	336	Q9Y5G5
TVLDVNDNAPEVVLT	PCDHGA12	336	O60330
EDQTQDTELVETRPA	HLA-H	246	P01893
RTVNRQDSDEQDPQE	KIR3DL2	381	P43630
DPVSQKNESVRNQVE	NCSTN	381	Q92542
NFSDTVQADPQTVTR	NCSTN	506	Q92542
DREEQPEVNLTITAV	PCDHB1	201	Q9Y5F3
NRPSTSQAARVEIQE	RADX	581	Q6NSI4
VDSNVPQIIRENSIS	ANAPC1	1426	Q9H1A4
RQSNSTAATNEVPEV	HLA-DQA2	101	P01906
ENTILPEEETVVQNT	KIF14	331	Q15058
QSQSPEVEQLGRVVE	NUP98	931	P52948
DESSNQRAEVVVQVP	ARHGAP45	986	Q92619
NFVSVTQEEDVPQVR	NCBP1	151	Q09161
ISSNNQERPTNREET	FER1L6-AS1	56	Q8NA97
AISVETPQDVLRASQ	GPA33	21	Q99795
DVTLQANNTSEDRPQ	KATNIP	166	O60303
ENPEETAARVNQSAL	APPL1	381	Q9UKG1
SSQETIQEVQPEEVL	GAPVD1	501	Q14C86
HTVEVRTQVQQPSDE	KDM6B	1241	O15054
NREPSSGQETEIQQV	DDX60	281	Q8IY21
ATDSVDVQSILPNRQ	FSIP2	1386	Q5CZC0
SSIPETQIQDRCQNV	FSIP2	5801	Q5CZC0
QDSQVNALEVTPDRS	MLST8	41	Q9BVC4
EDQTQDTELVETRPA	HLA-C	246	P10321
NLEETPVIENRSSQQ	PCM1	1561	Q15154
LVQVSITDENDNAPR	FAT2	2891	Q9NYQ8
SVEDVNDNRPEVTIT	PCDHGA9	336	Q9Y5G4
AILQVTVSDVNDNRP	PCDH9	236	Q9HC56
RATVTINVTDVNDNP	PCDH9	341	Q9HC56
AAVIVTVLDENDNSP	PCDH9	556	Q9HC56
VENSSLPQADEIQVI	PDE3B	1091	Q13370
ETISLQVEVESRNSP	EFR3B	696	Q9Y2G0
PNVTTVERNIDQEVT	GGTLC1	166	Q9BX51
TQTEKEDTSNINPRQ	MPHOSPH9	761	Q99550
LTPLNVQQAVDSRDS	MYO10	386	Q9HD67
DPQFQVVRTQETQEI	KRT78	101	Q8N1N4
APTVDLNQVLNETRS	KRT33A	216	O76009
NSITDPVLREAVEAQ	LRBA	2456	P50851
PDQNSDLQIRTVAIT	CD200R1	111	Q8TD46
VLNVSVETPENLAVD	LRP2	461	P98164
QNLTSAEVIVPRDQT	IGF2BP2	536	Q9Y6M1
ENLQRTTQPSINESE	NOL8	316	Q76FK4
AIISIRQEPTNSQID	PCDHA5	881	Q9Y5H7
STVRIVVLDVNDNAP	PCDHB10	226	Q9UN67
VEIPQVERNNSTESS	MFSD6	406	Q6ZSS7
EEAQARTQAQVNSPI	ARHGAP32	601	A7KAX9
EDQTQDTELVETRPA	HLA-B	246	P01889
AESQSQERISPQIQL	CRNN	171	Q9UBG3
EEVSPVSRQSIRNSQ	EPS8L2	446	Q9H6S3
SSVDVQSVEPVDQRT	MVP	636	Q14764
QSVEPVDQRTRDALQ	MVP	641	Q14764
EREDDLNVSVVVSPN	BBS9	406	Q3SYG4
PNVTTVERNIDQAVT	GGTLC3	166	B5MD39
AQDASPQSEIRAEEI	HMCN1	21	Q96RW7
NRAEDQTSPVVTTRN	PTPRQ	546	Q9UMZ3
ASNIIDAQNSRPIED	PROSER1	91	Q86XN7
PEVTSIVATVVDNEN	PRPF40A	316	O75400
AQISVRVLDTNDNSP	PCDHAC2	241	Q9Y5I4
VSVETIRNPQQQESL	BAG2	96	O95816
NSARQVVREPQDVSS	DYNC2H1	2036	Q8NCM8
SPRSNIDVNINSQEE	EPB41L5	521	Q9HCM4
QADPVVAVARDQSSV	HTT	946	P42858
VRSLEPQEIADVSVQ	ILRUN	131	Q9H6K1
LPNRDQTDDQVTIDS	IDH2	86	P48735
TNQINNPEVDVDITR	GPC6	441	Q9Y625
NTDQENRLESVPQAL	KDM3A	396	Q9Y4C1
LSAEEVRFPVSVTQQ	C2CD2L	156	O14523
EEVINLVDQTSENAP	ERN1	401	O75460
RTLLQQTQEEEPSTQ	ANKZF1	456	Q9H8Y5
EPTATVARVQEENEL	CROCC2	81	H7BZ55
ESQPLVQTAVTNIDR	FN1	1711	P02751
LIQTVSAVDQDDPRN	CDH20	511	Q9HBT6
PDSDTELRSQAVVDQ	FNIP1	761	Q8TF40
DPSQRDVISAQVAVI	FANCA	666	O15360
DTVTNRLVQPQDRQD	C3orf38	31	Q5JPI3
QQQEVISPDTTERNN	COL6A2	21	P12110
QNTVTIRFENVSPED	FAT3	3646	Q8TDW7
QVVEDSEPTRNQNFT	CEP162	771	Q5TB80
QIISLQTNDNDERSP	BRWD1	636	Q9NSI6
EDSTIPQASRLNNIV	BCL6	436	P41182
LQQAVPTESTDNRRV	EIF4G1	1126	Q04637
EDQTQDTELVETRPA	HLA-A	246	P04439
TQEEVQREQSQREAP	MAST4	1471	O15021
NESRQVLQEPDFAQS	FZD3	521	Q9NPG1
ETPVNDNSSIVVRIA	KIF5A	396	Q12840
DNSSIVVRIAPEERQ	KIF5A	401	Q12840
PTEVELDNQIVTATQ	JCHAIN	96	P01591
NPENRLRNSVVTQDD	DAZL	261	Q92904
LVQTEDNPRVAQVSI	EREG	51	O14944
PAQTREQSEEQITDV	FAF1	271	Q9UNN5
EQPQQNDESSSKVRT	HELQ	241	Q8TDG4
SVTVTVLDVNDNRPE	CELSR3	741	Q9NYQ7
QRQAEQEATVAPAEQ	CROCCP2	76	Q86T23
ENSINTEEVINAIAP	MTHFD1	106	P11586
NVVEQVRVQVSDPES	CIAO2B	66	Q9Y3D0
DPDEDISQTIENVRQ	MAP3K9	176	P80192
RKSAVEAQNEVTENP	LRRFIP1	616	Q32MZ4
SQSVASQDAQEIIRP	MIER1	136	Q8N108
LEQPATLQEVASQEV	PRDM2	221	Q13029
LTQSIQANVTVAPER	PKD1	2241	P98161
NVTDVNDNVPSIDIR	PCDH11Y	376	Q9BZA8
QNDTRVIQLNASDPD	PCDHA12	256	Q9UN75
AIISIRQEPTNSQID	PCDHA12	886	Q9UN75
LQERVVTVSGEPEQN	NOVA1	216	P51513
SEQDQDPQRVLSTLN	MCAM	471	P43121
SSNQEDAVIVEQPEV	MACROD2	356	A1Z1Q3
SNQIPTEVRSKAEEV	FUNDC2	151	Q9BWH2
RFQAPVDEQSESLQN	RNF207	551	Q6ZRF8
DVSDLRADDQVNQTP	TEX55	96	Q96M34
RADDQVNQTPSEQTK	TEX55	101	Q96M34
FTSETLEEQNVRNSP	TMEM26	191	Q6ZUK4
ERPAVSLTLDQSQSQ	SRRM2	1276	Q9UQ35
SQFQPVRSTEDEQEE	TEX14	1146	Q8IWB6
AQNREPESVEQLESR	SNX8	361	Q9Y5X2
EAAEQAERSQSSIVP	SMARCE1	306	Q969G3
AERSQSSIVPEEEQA	SMARCE1	311	Q969G3
LNVEVDTAPTVDLNQ	KRT34	251	O76011
LQEELENRTSETNTP	NIN	2011	Q8N4C6
QQPVISQEDRTRAST	RFFL	136	Q8WZ73
LTVRNQEDQRPTIAS	RGS20	221	O76081
VTPAVSVNNEVRTLD	TAF2	806	Q6P1X5
SVNNEVRTLDNLNPD	TAF2	811	Q6P1X5
TRVLSDNEEPISEVQ	NSUN7	141	Q8NE18
DTNRNQVLPLSDVDT	FASTKD2	611	Q9NYY8
NVVNVDFTPRSSTVE	SLC9A3	566	P48764
QELRVNNVTSPEFTS	SMG1	106	Q96Q15
NTVRRQEQPSIESTS	KIAA1217	1636	Q5T5P2
NAAVSILEEPQNRTS	SIPA1	191	Q96FS4
EEKPQEVQTSRNVES	SIRT1	576	Q96EB6
QDENQTSAITQRISP	TANC2	116	Q9HCD6
ARQPEEVVLQASVSS	MUTYH	66	Q9UIF7
VADVRTLPNASTVDN	MLH1	201	P40692
ATEARRVPEQQTQAS	NINL	121	Q9Y2I6
VRPNDEVTAVLAVQT	PIP	46	P12273
QAQPRSASDVEERVQ	SOS1	61	Q07889
ERIQSTQTVAPNDED	RASGRF1	186	Q13972
QTPDADLDVTNIIQA	AIMP2	81	Q13155
SIQEETEEVVNSQLP	CD300A	166	Q9UGN4
VSPSRELEQQQVSSR	CCNB1IP1	256	Q9NPC3
IDQVVQTALSETRDP	CLTCL1	971	P53675
LNNETRPSVQEDSQA	CNMD	241	O75829
ESQQTPARSLTLQEA	C10orf90	561	Q96M02
RTPEIVNIQETTNVN	TECTA	226	O75443
EEEIQQSEQHTPARQ	TMEM31	26	Q5JXX7
QEQTKTLRDSPNVEA	TRPS1	821	Q9UHF7
VTPTRAVTEQQEDLT	XKR6	541	Q5GH73
LLTEVAEDPQQVSTV	TXNDC16	251	Q9P2K2
VEDSLQAIVADSQVP	TEX13D	46	A0A0J9YY54
QSRTVRSENLEQVPQ	USPL1	911	Q5W0Q7
TDIDSPQNLVTDRVT	TNN	706	Q9UQP3
IEPANQELSSNIVEV	TPR	1786	P12270
QEVSREQQPSSASER	TPR	2051	P12270
QNEDIEPTSSRSNVV	WDR70	76	Q9NW82
TPEAELQALARDNTQ	RRS1	56	Q15050
PSTAQITEAQVAENR	PRND	41	Q9UKY0
DKNFTREQVTNEITP	SLC19A1	56	P41440
DQSRENSINPVQEEE	SPANXN2	71	Q5MJ10
ATTARQEEVPQQTVA	TNFRSF10C	26	O14798
TVETRDGQVINETSQ	VIM	446	P08670
IEEQQQTSHERPTDV	TANGO6	776	Q9C0B7
NELLTTTVPEIQRTN	DHX38	876	Q92620
DSTREPNSSAQIDIV	GART	826	P22102
NQTSRVVQAPKEEEE	SERPINA10	36	Q9UK55
INLLDPDTSQRQVDS	ZNF507	521	Q8TCN5
DLTAQEQNENVPIIS	ZNF277	416	Q9NRM2
PEQEEDRTVSLQNAA	TTC7A	366	Q9ULT0
EPQTLASTEQNEVPR	ZNF483	16	Q8TF39
TAVIEENPLVSNDRT	ZNF510	356	Q9Y2H8
RPTDDLQTIVAVAEQ	UBXN10	216	Q96LJ8
PRANITLQVSTAEDN	SLIT1	1186	O75093
ETTEKINAEREQPVQ	TUT4	751	Q5TAX3
LVEESNVQRVDSPVT	PPP4C	36	P60510
SEAEIQPQTQVTLRC	PTK7	136	Q13308
EALRQSRQTVPDVNT	TOPBP1	1121	Q92547
QETSPLRDAVVIEQS	TERT	781	O14746
PEEETTNAVESNNRV	MYO3A	1171	Q8NEV4
LSQNPVSQRDEATAE	GRIN2A	1026	Q12879